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Since the first use of nuclear magnetic resonance for tumor detection1 and the first imaging of
objects,2 magnetic resonance imaging has become a powerful tool in medicine. Whereas the
first images of human anatomy were clearly a tremendous success,3 it turned out that the use
of contrast agents (CA) can highly improve the performance and functionality of MRI.4,5
Though extremely successful, the true potential of MRI lies still ahead with its use as a
molecular imaging method.6 There are more sophisticated approaches under investigation
to gain a high local contrast in MR images, like hyperpolarization techniques7 or chemical
shift imaging,8 which however mostly are still under investigation or have not made it yet to
daily routine in clinics. Apart from these more sophisticated approaches, clinically approved
CA actually alter either the T1 or the T2 relaxation time of nearby proton spins.9,10 The key
parameter of these CA is the relaxivity, which is a measure of how bright or dark a signal
appears in the image.
Contrast agents, that alter the T1 time, also referred to as positive contrast agents, give
a bright signal in the image and are mostly based on gadolinium complexes. In fact and
right now, all of the U.S Food and Drug Administration (FDA) approved CA and which are
commercially available are of this kind.11 The second class of CA reduces the T 2 time, cancel
the signal and give rise to black spots in the image and hence are also known as negative
contrast agents. These CA are mostly composed from iron oxide. Although there are many
T 2 contrast agents which are FDA approved, nowadays there is none on the market, due to
poor demand.11 However, research in this area is still active and of increasing interest, since
iron oxide CA are potentially less toxic than the ones based on gadolinium.11
The development of MRI to a molecular imaging method calls for contrast agents, that
have relaxation rates which exceed the relaxation rate of clinical approved agents by several
orders of magnitude. A synthetical trial and error approach however is becoming more and
more unlikely to achieve high relaxivities. Hence, more effort is put on the understanding of
relaxation mechanisms generating a high MRI contrast.
5
1 Introduction
Different approaches have been developed to achieve high relaxivity T1 CA.9,12,13 All of them
have in common, that the rotation of the contrast agent complex is changed.1417 Another
kind of T1 CA are gadolinium complexes, that are encapsulated in polymeric nanocapsules
(NC).18 In this thesis, the FDA approved CA Gadovist is encapsulated and the resulting NC
are studied as potential high relaxivity CA, by investigating and analyzing important parame-
ters for the special circumstances that arise through the encapsulation. First, relaxivities are
investigated in different polymer solutions and for different conditions like different magnetic
fields and temperatures. Then, different capsule compositions will be investigated to reveal
their ability to work as high relaxivity CA. They will be measured by several NMR techniques
and compared to each other and to neat Gadovist solution. The findings from the mea-
surements in different polymer solutions will then be used, to further tune the relaxivity to
even higher values. Eventually, in-vivo imaging experiments will demonstrate the feasibility
of these contrast agents to tune the contrast in living objects and prove their potential for
medical applications.
For T 2 contrast agents, mostly superparamagnetic iron oxides (SPIO) are used, for which
the transversal relaxivity rate r2 is the key parameter. SPIOs can possess high magnetization
values and thus strongly affect T 2 . Therefore, they are ideal candidates for MRI exami-
nations.19 Since the first reports of SPIO size dependent relaxivities a lot of progress has
been made in this area to understand and tune the relaxivities to ever higher values.2022
However, the combination of a high contrast in imaging and a targeted drug delivery makes
SPIOs encapsulated in nanocarriers very promising and fascinating candidates as molecular
contrast agents.6,23,24 In this work, several SPIO based particle systems, including nanocap-
sules, are investigated with a focus on the understanding of NC as high relaxivity T 2 CA.
First, the particular relaxivities are simulated with theoretical approaches which are designed
for the understanding of SPIO clusters and nanoparticles (NP).10,25,26 In a second step,
the relaxivities are simulated using a different approach, namely with an empirical equation
found by Monte Carlo (MC) simulations, in which the special conditions arising through the
encapsulation process are included.27 Finally, both theoretical approaches and their outcome
will be compared with experimental results, again to evaluate the potential of nanocapsules
as high relaxivity contrast agents.
6
2 Theory
In this chapter the underlying physics of T1 and T2 relaxation with and without contrast
agents will be presented. It starts by explaining the concept of relaxation in NMR and the
different sources of relaxation. A more detailed theory for different relaxation mechanisms will
be introduced in the respective sections in the result chapter. Subsequently the theoretical
concept of relaxivity is introduced in section 2.1 as a measure for the effectiveness of contrast
agents. Thereafter the basics of MRI will be briefly introduced. Eventually, the difference
between T1 and T2 contrast agents will be elucidated and demonstrated by in vitro imaging.
2.1 Longitudinal and transverse relaxation
Nuclear magnetic resonance is based on the splitting of nuclear energy states in a magnetic
field B0.2831 The splitting of the energy levels arises from the Zeeman interaction of the
nuclear spin and the external field.28,30 At thermal equilibrium the energy levels possesses
slightly different spin populations which follow the Boltzmann distribution. This population
difference gives rise to a longitudinal magnetization, mostly referred to as z-Magnetization
Mz . The energy difference between the levels is given by the so called Larmor frequency !0,
which is given by
!0 = IB0 (2.1)
where I is the gyromagnetic ratio of the nucleus. With radio frequency (RF) pulses which
match the Larmor frequency, it is possible to saturate the transition between the energy
levels which results in the loss of longitudinal magnetization. The nuclear spins under inves-
tigation will also undergo thermal motion and feel the local magnetic field induced by other
molecules.29 If the thermal motion makes the local field induced by other molecules oscillate
close to the Larmor frequency, the spin will be rotated into a new direction, similar to applying
an RF pulse. Since the spins have a higher energy after applying an RF pulse, this thermal
motion induced relaxation is a natural way of loosing this energy and coming back to thermal
7
2 Theory
equilibrium. Hence, this relaxation is connected with a change of energy and it is the thermal
energy of a system, with which the spin energy comes into equilibrium. This mechanism is
called longitudinal relaxation and the time constant for this process is the T1 relaxation time.
The inverse of the T1 time is the T1 relaxation rate constant R1, which is a measure for how
fast the magnetization comes back to thermal equilibrium. At equilibrium, the magnetization
has only a z component. But directly after a 90 pulse exists no z component, but only
x and y components in the transverse plane, see also Figure 2.1. These components give
Figure 2.1: At equilibrium it exists only a magnetization in z direction, indicated by the green arrow.
After a 90 pulse (gray bar), there are only components in the x and y plane. Over
time, the magnetization in the x/y plane relaxes to zero, whereas the magnetization in
z-direction builds up again, thus recovering the thermal equilibrium.
rise to a transverse magnetization in x/y plane.29 Of course, thermal motion and therefore
oscillating local fields can again bring these magnetic components into new directions. But
more importantly, because of local fields in z-direction, which change the external magnetic
field, different spins will precess at different Larmor frequencies. They will therefore dephase
in the x/y plane and lose their coherence between each other. This kind of relaxation is
called transverse relaxation or T2 relaxation. Analog to R1 the inverse of the T2 time is R2.
Unlike the longitudinal relaxation, the transverse relaxation is not causing any energy change
in the system.
2.2 Correlation and spectral density functions
Since the thermal motion in the end gives rise to the relaxation of magnetic moments, a
measure is needed, which describes how fast and effective the reorientation of spins take
place. This can be done by correlation times and the corresponding functions.29 The corre-
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lation time fic describes how long it takes for an ensemble of spins to reorient their magnetic
moments by a certain degree. If a spin i experiences at a time t a field Bi(t) and because of
thermal motion at a time t + fi a different field Bi(t + fi), the so called correlation function






Bi(t)Bi(t + fi) = B(t)B(t + fi) (2.2)
For long times fi the local fields will have all kind of orientations, such that the average over
the whole sample will be zero and hence the correlation function will be zero. Since the exact
point at which the observation starts is not of interest, the time point t usually is set to zero.
The correlation function then can be written as G(fi). For fi = 0, the correlation function is
simply
G(0) = B2 (2.3)




where fic is the correlation time, characteristic for the motion of the spin. However, fic is
yet unspecified. Apart from other reasons, it is important that the local field oscillates close
to the Larmor frequency to be an efficient source of relaxation. Therefore it is interesting to
have a function, describes this effect in the frequency domain rather than the time domain.
This gives rise to the spectral density function J(!), which is connected with the correlation
function via a Fourier transformation FT 29




The general behavior of these functions is shown in Figure 2.2. As one can see, the correlation
function decays faster for shorter correlation times fic . And the spectral density function
decays faster for longer fic , whereas for short fic the spectral density function shows a broad
distribution of frequencies. However, only frequencies lead to reorientations which are close
to the Larmor frequency !0. Hence, the spectral density function at the Larmor frequency
9
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Figure 2.2: Left: Correlation function for two different correlation times fic . For the blue curve,
the correlation time fic is chosen two times longer than for the black curve. Right:
Spectral density function for two different correlation times. Again, for the blue curve,
the correlation time fic is chosen two times longer than for the black curve.







It can be easily verified, that the maximum of the spectral density is reached for !0fic = 1,
which is equivalent to fic = 1/!0. Interestingly the relaxation rate R is proportional to the
spectral density function J(!0). It should be mentioned that B is the strength of the local
field, which is very high for paramagnetic species and if the field changes at the right frequency
due to thermal motion, this resembles a highly efficient source of relaxation. If B as well
as the correlation time is known, the relaxation rate can be calculated with help of equation
2.6. In the result chapter, the spectral density functions and B will be calculated explicitly.
As already mentioned, the relaxation mechanisms relevant for T1 relaxation can also drive
the transverse magnetization to equilibrium. However, in case of transversal relaxation, a
second mechanism exists. Since the relaxing spins will not only feel the external magnetic
field B0 but in addition the z-component of local fields, the Larmor frequency is different
for every spin in the solution. This causes the individual spins to precess at different Larmor
frequencies, hence they start to dephase and the transverse magnetization decays. In fact,
this is a very powerful way of relaxation. It can be shown, that this gives rise to a second
10
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In order to illustrate equation 2.6 and 2.7, they are plotted in Figure 2.3. The Larmor
Figure 2.3: Spectral density function J(!0) for different correlation times fic , for the longitudinal
relaxation (blue) and the transversal relaxation (black).
frequency was set to 64 MHz, which corresponds to the field strength of most clinical MRI
scanners of 1.5 T. As one can see, there is a distinct maximum at a correlation time of
around 15.6 ns, which corresponds to 1=fic = !0 = 64 MHz, like expected. However, the
important consequence is that for longitudinal relaxation no general rule applies e.g. like
longer correlation times result in higher relaxation rates. For every Larmor frequency, there
is an optimal correlation time, it must not be too long nor too short. This is a crucial step in
designing contrast agents. A second consequence is, that the maximum value of the spectral
density function for longitudinal relaxation rate is given by B2. Eventually, that means that
the maximum of the relaxation rate is given by the strength of the local magnetic fields B,
which are given by the molecules in solution and that the highest relaxivity is centered at
the correlation time, that corresponds to the Larmor frequency. In contrast, the transversal
relaxation given by equation 2.7 has a second term, which in opposite to the first term has
no maximum, but is steadily increasing with increasing correlation time fic . This is the reason




So far, only the difference between R1 and R2 has been described but not the different
physical sources of local fields. The dominant ones are dipolar and chemical shift anisotropy
mechanisms. Apart from that, a very efficient relaxation by paramagnetic species exists,
which will be discussed in the next subsection. The dipolar relaxation mechanism is induced
by magnetic moments of adjacent spins, irregardless if they are from other molecules or
from a neighboring spin within the same molecule. Since there is one spin generating the
field and another spin experiencing it, this mechanism is called dipole-dipole interaction.29 It
falls off rapidly with 1
r
3 , where r is the vector connecting the two dipoles. The strength is
proportional to the gyromagnetic ratio I of a spin. A higher gyromagnetic ratio leads to a
larger magnetic moment and hence to a stronger interaction. Another source is the chemical
shift. That is electrons in a molecule give rise to a local field at the nucleus and therefore the
spin under investigation. Again due to thermal motion, this local field permanently changes
and can cause relaxation of the spins. In principle all relaxation mechanisms for T1 affect
also T2.
2.4 Relaxation induced by paramagnetic species
As already mentioned, another source of relaxation are paramagnetic species, which is the
most important relaxation mechanism in this work. Paramagnetic relaxation comes from
dipolar interactions. But this time it is not induced by an interplay between only nuclear
spins but by the spins from unpaired electrons, affecting the investigated nuclear spins. As
already noted in the previous section, the strength of the dipolar interaction is proportional
to the gyromagnetic ratio. Due to the fact, that the gyromagnetic moment of an electron
exceeds the one of a proton by the factor of 650, dipolar interaction with unpaired electrons
is a very efficient way of relaxation.30 Typically, one tries to avoid paramagnetically impurities
for instance by O2 gas, that has unpaired electrons which again results in fast relaxation.
However, in the case of MRI contrast agents, this is exactly what is tried to achieve in a
controlled manner. To differentiate it from all other relaxation pathways Rdiai , it will be
12
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i i 2 f1; 2g (2.8)
The paramagnetic relaxation is dependent on the concentration [c ] of paramagnetic species,
Rparai = ri [c ] i 2 f1; 2g (2.9)
Here the so called relaxivity ri is introduced. It is one of the most important parameters for
contrast agents, since the paramagnetic relaxation rate and therefore the total relaxation
rate is linear proportional to the relaxivity. The paramagnetic relaxation rate usually exceeds
the diamagnetic rate by several order of magnitudes and is therefore a highly efficient way
to locally alter the relaxation rate. Since this high relaxation rate provides a good contrast,
paramagnetic species are often used as contrast agents. Depending on if a paramagnetic
species mainly changes the T1 or the T2 time, the according complex is called T1 or T2
contrast agent. There are several comprehensive review articles on T1 contrast agents9,13,32
and T2 contrast agents,10,22,33 in which more details can be found. The most important
aspects and differences between the two relaxation mechanism will be discussed in the result
chapter.
2.5 Superparamagnetism
In fact most of the negative contrast agents are superparamagnetic, rather than param-
agnetic. Superparamagnetism has been predicted by Frenkel et al.34 and experimentally
observed by Bean et al.35 Ferromagnetica show typical hysteresis curves in external mag-
netic fields.36 Once ferromagnets are magnetized, they keep their magnetization known as
remanence, because of single magnetized Weiss domains. If a ferromagnet is heated above
a certain temperature, i.e. the Curie temperature, it looses its remanence. The reason is
that at this temperature the thermal energy is high enough to randomly reorient the before
aligned electronic spins in the Weiss domains.36 The spins are kept aligned by the anisotropy
energy barrier
EA = K  V (2.10)
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with K being the anisotropy constant and V the volume, for example of a ferromagnetic















and the Néel relaxation
fiN / eEA=kBT (2.13)
where all parameters have their usual meaning. One should note, that fi in this case refers to
the relaxation of the electronic moment and not to the nuclear spin relaxation. If the particle
gets smaller, the energy barrier decrease as well. Below a size of typically some tenths of
nanometers, the spins reorient all the time. That leads to paramagnetic behavior of formerly
ferromagnetic materials. Thus, the term superparamagnetism is somewhat misleading since
in fact the underlying materials are ferromagnetic. Superparamagnets usually have a very
high permeability r due to their ferromagnetic nature. Considering that the magnetization
M / rH, with H being the external magnetic field strength, superparamagnets are excellent
negative contrast agents, as will be shown later.
2.6 MRI fundamentals
So far the discussion included only NMR spectroscopy. Contrast agents, however, are mainly
used in magnetic resonance imaging (MRI). In MRI spatially encoded signals are generated,
which eventually leads to the use in medicine. For the following explanation an NMR tube
filled with water is assumed to be measured in an MRI scanner. If a field gradient Gx is
applied along the x-axis like in Figure 2.4 the Larmor frequency will differ along the x-axis
because of37
!0(x) = I(B0;x + Gxx) (2.14)
Now one can differentiate different spin positions along the x-axis. This is the so called
14
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Figure 2.4: Tube filled with water in an MRI scanner with applied field gradient Gx in x-direction and
Gy in y-direction respectively, which are colored red. The Larmor frequency !L increases
with increasing gradient strength in x direction. With increasing gradient strength in y
direction increases the phase difference '.
frequency encoding step. The signal S(t) coming from the sample along the x-axis then is38
S(t) =
∫
(x)  exp(iIGxxt)dx (2.15)
where (x) denotes the spin density. A second gradient is applied in y direction to change
the phase of the spins, hence it is also called phase encoding gradient.37 Depending on
the position of the spins in the sample, the gradient increases or decreases the local field.
Therefore, some spin packages will precess slower than the Larmor frequency and others
will precess faster. Thus they begin to dephase, analog to T2 relaxation, but in a controlled
manner. If the gradient is switched off after a certain time the spins will have the same Larmor
frequency again but different phases. This step is called phase encoding and is necessary to
probe the second spatial dimension. The amplitude of the phase encoding gradient gets
larger with every step. The reason for this is easier to explain in the so called k-space, see
Figure 2.5. First one defines the reciprocal space vector
k = IGt (2.16)
where G is the gradient in two dimensions and t the time. Assuming that the spin density
at a certain place is (r), the two dimensional form of equation 2.15 is
S(k) =
∫
(r)  exp(ikr)dr : (2.17)
15
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Figure 2.5: Depiction of k-space.
Thus the signal intensity in the k-space is related to the spin density in normal space with a
Fourier transformation.
If the gradient Gy is not changing, the same line of kx would be sampled in every step.
If the amplitude of the gradient Gy increases in every step by G, ky increases to ky =
I(Gy + Gy )t. This corresponds to the next line of ky in k-space. To cover the whole
k-space the Gy gradient needs to become stronger with every step.38 Eventually a set of
position encoded signals is collected, which can be reconstructed via Fourier transformation
in order to obtain an image. So far the signal intensity only depends on the spin density and
the location. In fact the signal intensity in MRI also depends on both the T1 and the T2
time,37









where S0 is the signal intensity at zero time, tR the repetition delay between different ex-
periments, and tE the echo time, which is the time between the excitation pulse and the
signal detection during which the echo occurs. To illustrate equation 2.18 it is calculated
and displayed in Figure 2.6. The shorter the T1 time and the longer the T2 time, the higher is
the signal intensity. Correspondingly a high signal intensity for short T1 times can be reduced
by a short T2 time. This is the reason why MRI resolve the anatomy of the body, because
of different relaxation times in different body regions. This is where contrast agents come
into play and their use in MRI, in order to change relaxation times in a controlled manner.
Thus, even if in most cases the performance of a contrast agent is discussed on the basis of
16
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Figure 2.6: Signal intensity for different T1 and T2 times for a fixed repetition delay tR of 300 ms and
echo time tE of 5 ms.
either its R1 or R2 rate, one should keep in mind that both rates are of importance. Still,
it is uncommon to equivalently report both values. Moreover one should keep in mind, that
the actual contrast also depends on the values chosen for tR and tE .
2.7 Comparison between positive and negative contrast agents
To get an impression how contrast agents are working, a so called T1 map (Left side of
Figure 2.7) and a T1 weighted image (right side) of three Magnevist containing samples was
recorded. A T1 map is simply an image, which graphically shows the T1 time of different
regions, in this case of the three different sample tubes. Magnevist is a commercially available
gadolinium based T1 contrast agent. The samples are numbered according to an increasing
concentration of Magnevist. In a T1 weighted image the repetition delay between subsequent
scans is chosen to be on the order or shorter than the average T1 time of the sample. Thus,
the time to recover the magnetization is too short for regions which exhibit long T1 times.
That leads to diminished signal intensities for samples with a long T1 time and high intensities
for samples with a low T1 time.
Both images show samples with equal amounts of water, but different concentrations of
17
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Figure 2.7: T1 map and T1 weighted image of Magnevist in 1 wt% Agarose. Samples are numbered
in accordance to an increasing concentration of Magnevist. Repetition delay for the T1
weighted image was 150 ms and tE 1.6 ms.
Magnevist. The T1 time depends on the Magnevist concentration, with a decreasing T1
time for increasing concentrations. If for the same samples a T1 weighted image is recorded,
the signal intensity is proportional to the concentration of Magnevist. The reason is an
only partial recovery of the magnetization for samples with high T1 times. If the repetition
delay is chosen short, the time for recovering the magnetization is too short for samples
with a low concentration of Magnevist. That leads to a diminished signal intensity in this
T1 weighted image. On the other hand, if the concentration is high a bright signal can be
observed, although the repetition delay is short. This is why these kind of especially T1
reducing contrast agents are also called positive contrast agents.
The counterpart to a T1 weighted image is a so called T2 weighted image. Normally the echo
time for MRI is chosen as short as possible, in order to obtain the maximum intensity, see also
equation 2.18. In a T2 weighted image, a rather long echo time is chosen. Thus the intensity
decreases for samples with short T2 times. To demonstrate this behavior, a T2 map (left side
of Figure 2.8) and a T2 weighted image (right side) of magnetite containing nanocapsules
(named NC-250 which will be introduced in the result chapter) were recorded. As one can
see and in opposite to Magnevist containing samples, the intensity is diminished to almost
zero for sample 3, which has the highest magnetite concentration. Therefore, it is possible
to distinguish areas with high magnetite concentration from those with no magnetite. The
vanishing signal intensity is the reason why these predominantly T2 reducing contrast agents
18
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are also called negative contrast agents.
Figure 2.8: T2 map and T2 weighted image of magnetite containing samples. Samples are numbered
in accordance to an decreasing amount of magnetite. Repetition delay for the T2 weighted
image was 15 s and tE 4.6 ms.
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3 Methods and materials
In this chapter the experimental setup as well as important measurement sequences will be
introduced.
3.1 NMR scanner
Several magnets have been used for relaxation rate measurements and imaging. The first
one, which has also been used for the in vitro MRI in the last chapter, was a 4.7 T horizontal,
20 cm-bore solenoidal magnet (Magnex Scientific Ltd., UK). It was equipped with a Maran
DRX spectrometer from Oxford Instruments (Oxfordshire, UK) and a SGRAG 195/120/S
12 cm-bore gradient system from Magnex Scientific Ltd. (Oxford, UK) with a maximal field
gradient strength of 2.0 T/m.
Due to a movement of the equipment from the MPI for Polymer Research to the physics
department of the Johannes Gutenberg University (Mainz), the horizontal NMR scanner has
been replaced by a vertical one (Bruker / Spektrospin, UK). The vertical magnet is equipped
with the same Maran DRX spectrometer from Oxford Instruments (Oxfordshire, UK) as used
before. The gradient system was a micro imaging system (Micro 2.5 Bruker, UK). Everything
else was left unchanged. The used coils were a single resonant coil R1/20 40 MI 200 or a
double resonant R1/13 20 MI 200 (m2m Imaging Corp., USA), both in birdcage geometry.
For reasons, that will be shown later, the vertical 4.7 T scanner has been discharged to a
field strength of 1.5 T later on. More details can be found in the result chapter 4. A single
resonant coil originally designed for 300 MHz Xenon NMR has been modified to match the
proton frequency of 64 MHz, corresponding to the Larmor frequency of protons at 1.5 T.
For high field measurements a superconducting magnet operating at 300 MHz Larmor fre-
quency equipped with a Tecmag console was used.
For temperature controlled experiments, samples were heated to 37 C in a tempered wa-
ter bath prior to measurements. Temperature control during measurement was achieved
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in the NMR coil by application of a tempered stream of nitrogen gas using a home-built
liquid nitrogen evaporator and a VT-1000 temperature controller from Bruker (Karlsruhe,
Germany).
3.2 NMR relaxation rates
The longitudinal relaxation times 1H-T1 were measured with an inversion recovery sequence.29
For the determination of one T1 time the spectra for 15 different relaxation delays were
recorded. The resulting spectra were integrated and the data points fitted with a mono-
exponential curve in order to determine the T1 time via
M(t) = M(t = 0)e t=T1 + c (3.1)
where t is the time between the RF pulse and the data acquisition,M(t) the magnetization at
time t and c the noise. Whenever a multiexponential analysis was performed, the geometric
mean (gm) T1 or T2 time was calculated, respectively.39
The transverse relaxation time 1H-T2 was measured with a Carr-Purcell-Maiboom-Gill (CPMG)
echo train.40 The echos were integrated and the resulting data points fitted with a mono-
exponential curve in order to determine the T2 times. The equation is similar to equation
3.1 only with T1 now being T2.
The transversal relaxivity can depend on the echo time of the CPMG sequence, as will be
shown later (Equation 4.38 in chapter 2). To keep the influence of the sequence as small
as possible, the shortest possible echo time was chosen. The measured data have been
evaluated with a home written code in Matlab R2012a, see section 8.3.1.
In both cases, for the determination of the relaxivities r1 and r2, a linear fit was applied
Ri = R
dia
i + ri [c ] i 2 f1; 2g (3.2)
For some measurements water as well as 1 wt% agarose was used as sample matrix. Agarose
is known to influence the relaxation rate, via chemical exchange between the hydroxyl protons
on polymer side-chains and the protons of bulk water.41 However this only affects the
diamagnetic part of the total relaxation rate. Thus the total relaxation rate can change,
without a change in relaxivity, see equation 3.2.42,43 Therefore it does not matter for
relaxivity measurements if agarose or water is used as sample matrix.25
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3.3 Diffusion measurements
For the determination of diffusion coefficients of water in nanocapsules, diffusion ordered
NMR spectroscopy (DOSY-NMR) has been performed with help of Dr. Manfred Wagner
(Max Planck Institute for Polymer Research). The NMR scanner was an Avance-III operating
at 700 MHz from Bruker (Karlsruhe, Germany). The used probehead was a 5 mm 1H/X coil
for heteronuclear detection. Here, the second nucleus was 17O. In addition the probehead
possesses a z-gradient with maximum gradient strength of 0.4 T/m. The temperature was
set to 298 K. The diffusion measurements were performed using a 2D DOSY sequence.44
In order to increase the 17O signal intensity, an Insensitive Nuclei Enhanced by Polarization
Transfer (INEPT) sequence with proton decoupling was used.29 For one measurement the
gradients were increased linearly in 16 steps. To calculate the diffusion coefficient, the Fourier
transformed free induction decay (FID) were integrated and plotted against the according
gradient strength. Then a mono-exponential decay was fitted to the data points







where G is the gradient strength, I(0) the intensity without applying a gradient,  is the
duration for which the gradient is switched on, and  is the diffusion time, hence the time
between the two gradients.
3.4 MRI pulse sequence
In this work, a so called spin echo (SE) sequence have been used exclusively for MRI. In the
SE sequence, the echo is induced by a 180 pulse after the phase encoding and first read
gradient. The advantage of the SE sequence in comparison to a gradient echo sequence is
that the signal only decays with T2 and not T 2 , because field inhomogeneities are refocused
by the 180 pulse.37 Additionally the SE sequence is less sensitive to susceptibility artifacts.45
The disadvantages are a longer scan time and more applied rf-power because of the additional
180 pulses. For the denotation of the parameters see also section 2.6 in chapter 2.
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Figure 3.1: Sketch of the Spin echo sequence used in this work. The blue arc in the read out gradient
depicts the echo.
3.5 Exchange measurements
In this thesis, it has turned out, that the water exchange from the bulk phase to the core
of nanocapsules is very important for the efficiency as contrast agents. There are several
NMR techniques, that are able to measure the water exchange between different phases, for
example Diffusion Exchange Spectroscopy (DEXSY)46 or Altered Relaxation Times Detect
Exchange Correlation (ARTDECO).47 The concept behind this kind of exchange sequences
is the same, no matter if the diffusion (DEXSY) or T2-time (ARTDECO) is recorded. In this
work, ARTDECO has been used.48 ARTDECO can differentiate between two environments
in a solution exhibiting different T2 times, see also sketch 3.2. Bulk water has a certain
T2 time, which will be named T2;2. However, in the case of water in a nanocapsule, the
water will experience different local fields than the bulk water and therefore has a different
T2 time, which will be named T2;1. The idea is, that at time zero, the T2 time of the sample
will be measured resulting in two T2 times, one coming from the bulk, one stemming from
the close environment of the capsule. After a so called exchange time fin, the T2 time is
measured again. For fin = 0, there are a11 water molecules, with T2 times T2;1 and a22 water
molecules with a T2 time of T2;2. At time zero no exchange took place and a12 and a21
are simply zero. If the exchange time is fin 6= 0, a12 water molecules will diffuse from the
capsule into the bulk phase and a21 molecules from the bulk phase into the capsule. Hence,
these molecules experience different T2 times. The longer fin is, the more water molecules
will change their environments and the fewer will stay in their initial environment. In the
experiment, the exchange time is increased stepwise and the amplitudes of the corresponding
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Figure 3.2: Sketch of a nanocapsule (black dashed lines) and water (blue spheres). The coefficient
amn, where m; n 2 f1; 2g, represents the number of water molecules in a certain envi-
ronment. In total a22 water molecules diffuse in the bulk, a11 diffuse in the capsule, a12
exchange from the capsule to bulk and a21 exchange from bulk to the capsule.
signals will be compared. For short exchange times, there is a big amount of molecules, that
does not change its environment, resulting in large a11 and a22 and small a12 and a21. With
increasing exchange time, more and more molecules will change their environment, hence
a11 and a22 start to decrease, whereas a12 and a21 start to increase. By altering fin, the
exchange time for which molecules start to exchange from capsules to bulk and vice versa is
measurable. To underline the physical meaning, it is helpful to look at the extreme situations.
One is no exchange at all, for instance for a capsule that is impermeable to any molecule.
The coefficients a11 and a22 would then just reflect the amount of water inside and outside
the capsules, respectively. On the other hand, in case of very fast exchange, where a water
molecule experiences all environments within the given exchange time, the individual T2 times
and amplitudes loose their meaning. Instead an averaged T2 time and an averaged amplitude
will be measured. The sequence is shown in Figure 3.3. The delay fi is 350 s. The variable
n is incremented logarithmically in order to avoid long measurement times. The resulting 2D
data set had a size of 1024 times 128 and was fitted directly in the time domain with a two
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Figure 3.3: Sketch of the ARTDECO pulse sequence, not drawn to scale. The echo time tE between
two 180 pulses equals 2fi . The exchange time is fin. In the first block m and in the
second block n echos are acquired, respectively.
dimensional fit,
S(m; n) = a11  e t1=T2;1  e t2=T2;1 + a12  e t1=T2;1  e t2=T2;2+
a21  e t1=T2;2  e t2=T2;1 + a22  e t1=T2;2  e t2=T2;2
(3.4)
where S(m; n) is the signal intensity, the parameters amn, T2;1 and T2;2 have their meaning
like defined above.
3.6 NMR Dispersion
As shown in section 2.1, the relaxivity depends on the Larmor frequency. In fast field cy-
cling (FFC) measurements the T1 time for different magnetic field strengths is accessible,
resulting in the relaxation rates for different Larmor frequencies, also known as NMR dis-
persion (NMRD) profiles.49,50 Fitting of an appropriate model can give access to different
correlation times.51 The FFC measurements have been performed by Dr. Oliver Neudert
(Max Planck Institute for Polymer Research) at the Ilmenau University of Technology on a
Fast Field Cycling (FFC) relaxometer (Spinmaster FFC2000, Stelar s.r.l., Pavia, Italy) for
magnetic field strengths in the range of 0.23 mT to 0.54 T.
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In this chapter, the T1 and T2 contrast agents will be characterized. It consists of two parts.
The first section deals with positive T1 contrast agents. The second section shows the results
on negative T2 contrast agents.
4.1 Positive contrast agents#
This section starts with a more detailed theoretical approach describing gadolinium contain-
ing contrast agents. Subsequently the relaxation rate for Gadovist at different magnetic
fields, temperatures and in different polymer solutions is investigated and simulated. Hav-
ing established a general understanding of relaxivity, section 4.1.5 deals with the exchange
of water molecules and protons in general in and out of nanocapsules. Thereafter, differ-
ent nanocapsule systems are introduced and discussed as high relaxivity contrast agents. In
the end, in vivo experiments demonstrate the value of the investigated systems as contrast
agents.
4.1.1 Theory of longitudinal relaxivity
Before describing nanocapsules as T1 contrast agents, it is helpful to look at the relaxivity
of different solutions and to establish the theoretical concept behind r1. One should keep in
mind, that the relaxation rate is proportional to the relaxivity. The longitudinal relaxivity r1











#This section is based on the publication "Increasing relaxivity of magnetic resonance contrast agents induced
by confinement in semipermeable nanocapsules" by Kerstin Malzahnz, Sandro Ebertz, Isabel Schlegel,
Oliver Neudert, Gunnar Schütz, Andreas Ide, Farnoosh Roohi, Daniel Crespy, Kerstin Münnemann, Katha-
rina Landfester, currently under review at Advanced Healthcare Materials.z: Authors contributed equally.
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with IS and OS denoting the inner and outer sphere, respectively. The inner sphere contri-
bution arises from molecules temporarily bound to a paramagnetic center of a molecule and
the dipole-dipole interaction between the ion and the hydrogen of a molecule.52 This kind of
interaction has been described by Solomon, Bloembergen, and Morgan and is consequently
called SBM theory.5355 In most T1 contrast agents the paramagnetic center is a gadolinium
Figure 4.1: Inner sphere relaxation by water molecules temporarily binding to an ionic center (Orange
sphere inside orange circle). The correlation time describing the water molecule binding
is the water exchange time fim.
ion (Gd3+) which is incorporated in a chelate complex, because of its toxicity.9,56 Often
only the hydrogen atoms of water are regarded as the relaxing molecule. However, every
hydrogen atom of any solvent molecule can be relaxed, as also stated by Bloembergen and
Morgan.9,32,55 However, because the gadolinium ion is bound to a chelate complex, only
small molecules can approach close enough to interact with the electron. In addition, the
partially negatively charged oxygen of water can temporarily bind to the positively charged
gadolinium ion. Therefore, water is considered as the most important molecule to be relaxed,
strictly spoken the hydrogen atoms of it. After a characteristic water exchange time fim, a
water molecule from the inner sphere exchanges with a water molecule from the outer sphere
which is not yet relaxed. Due to this reason a fast water exchange is favorable up to a certain
limit, because more protons can be relaxed. However, the water exchange must not be too
fast, to ensure effective relaxation. This allows the propagation of the relaxing effect to
the entire solvent.56 Due to this exchange the inner sphere contribution is sometimes called
chemical exchange model.56
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In equations 4.2 pm refers to the mole fraction of metal ion, q to the number of bound water
molecules per metal ion, fim the residence time of the water molecule at the metal ion, and
T1;m the T1 time of the solvent molecule in the inner sphere, respectively. The latter must
not be confused with the total T1 time of the system.










with T S1 and T
D
1 denoting the scalar and dipolar term, respectively. The scalar term stems
from the hyperfine interaction between the electrons of the Gd3+ and the nuclear spins of
the water protons and the dipolar term from electron nuclear spin coupling. Before making
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(4.4)
with 0 being the permeability of vacuum, I the nuclear gyromagnetic ratio, r the distance
between the metal ion and the proton, !I and !S the proton and electron Larmor frequencies,
respectively. One should note that the theory was derived in the early 50ies of the last
century. At that time the Système international d'unités (SI) system was not yet established.
Therefore, the constant C is often given in Gaussian Centimetre Gram Second (CGS) units.54
For the CGS system the relation BCGS =
√
4=0BSI holds true, where BCGS;SI denotes
the magnetic flux density in the Gauss CGS and the SI system, respectively.54,56

































At this point, one should note the analogy of the equations above to the equations given in
section 2.2. There it was shown, that the relaxation rate is proportional to the strength of
the local magnetic field and the spectral density function. In equation 4.5 the strength of the
local field is given by C, which is basically determined by the gadolinium complex, whereas the
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the spectral density function is given by the other terms of the equation. If the parameters
are known, the relaxivity and therefore relaxation rate in solution can be calculated. This will






















i 2 f1; 2g (4.8)
T1;e and T2;e are the electron longitudinal and transversal relaxation times of the metal ion,
fim the residence time of the water molecule at the Gd ion, and fir the rotational correlation
time. For the interpretation of the results, it is important to note, that the electronic
relaxation times are increasing quadratically with magnetic field.52 For spherical molecules





with  being the viscosity, and r the radius of the molecule.






































The scalar contribution is usually not very efficient in comparison to the dipolar relaxation.
Because of the temporarily binding of the water molecule to the paramagnetic center the
proton is two bonds separated from the gadolinium ion. This makes the hyperfine coupling
constant A
~
from the electronic spin of the gadolinium ion to the nuclear spin of the proton
relatively small.9 In addition, it is dependent on !S and therefore decreases rapidly already
at low fields.
In a second step, the outer sphere contribution is introduced. Outer sphere relaxation has
been described by Ayant et al. and later by Freed, who took into account the volume excluded
by the paramagnetic center.58,59 The outer sphere part stems from water molecules passing
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Figure 4.2: Outer sphere relaxation stems from water molecules passing the magnetic moment m of
a paramagnetic center.
the magnetic moment of the paramagnetic complex. The determining correlation time for





where d denotes the distance of closest approach between the solvent molecule and the
complex and D the relative diffusion coefficient between the paramagnetic complex and the
solvent molecule.59 The relative diffusion is given by
D = Dp +Ds (4.13)
where Dp and Ds stand for the diffusion coefficient of the paramagnetic complex and of the
solvent molecule respectively. By this definition fiD is the time that a solvent molecule needs
to diffuse a distance of
p
2d.60 According to Freed, outer sphere relaxation is only governed










[7j(!SfiD) + 3j(!IfiD)] (4.14)
with
j(!; fiD) = Re

























In equation 4.14 NA denotes the Avogadro constant and in 4.15 Re stands for the real
part of and ! for !S or !I , respectively. All other parameters are denoted like above. The
magnetic center is normally much bigger than the water molecule, due to its chelate complex
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resulting in slow diffusion of the complex. Hence, the relative diffusion coefficient is replaced
by the self diffusion coefficient of water, which is 2.2710 9 m2/s at room temperature.61
From the introduced formulas one can understand why mostly ions like Gd3+ are used.
Because of seven unpaired electrons Gd3+ has a spin quantum number S of 7/2. Since
Ri / S2 is valid for all relaxation rates, a high spin quantum number S is very desirable. Since
!S  650!I , terms with !S in the denominator decrease rapidly with increasing field.13,31
Thus, terms with !S can be neglected for magnetic fields higher than a few mT, like for
example the complete scalar contribution given by equation 4.6, in addition to the reasons
already mentioned.
Apart from the parameters introduced above, which are mostly given and hardly changeable,
especially the rotational correlation time fir has attracted a lot of interest.62,63 This param-
eter can be altered by changing the environment of the metal ion, like encapsulation,17,6466
immobilizing on particle surfaces,67,68 attaching different surfactants or grouping several
ions together in a hyperbranched polymer,69,70 just to name few.13,71 The SBM theory
for low molecular gadolinium-based contrast agents in water is able to properly describe the
relaxation rates over a broad range of different magnetic fields.9 With the above introduced
equations, the relaxivity can now be simulated in a semi-empirical approach. For that, ex-
perimentally gained literature values are inserted in the above equations. Then the relaxivity
can be simulated. Details can be found in section 7.1.1. In Figure 4.3 the influence of the
rotational correlation time fir on r1 is simulated. The lines show relaxivities for different water
exchange times fim. The black line corresponds to commercially available contrast agents
like Magnevist or Gadobutrol. Their rotational time is around 50 ps. To see the influence of
fir , the simulation is performed with fir = 125 ps (blue line). One can see that the relaxivity
has doubled in case of the slowly rotating agent.
4.1.2 Relaxivity in solution
Commercially available and FDA approved contrast agents like Magnevist and Gadovist in
solution have rather low relaxivities, between three and five s 1mM 1, depending on their
local environment. The actual chelate complex in the Gadovist solution is called gadobutrol.
For gadobutrol in water, the relaxivity r1 is 2.8  0.1 s 1mM 1in blood plasma the value
31
4 Results and Discussion
Figure 4.3: Relaxivity r1 for a rotational correlation time fir of 54 ps (black line) and 125 ps (blue
line).
is reported to be 5.6 s 1mM 1.72 Different environments typically also have different vis-
cosities. Since the rotational correlation time fir and the diffusional correlation time fiD are
proportional to the viscosity, that leads to different relaxivities. An easy way to change the
viscosity is the introduction of sucrose into a solution of gadobutrol and water. It has already
been shown that sucrose can mimic an in vivo environment.73 On the left side of Figure 4.4
Rdia1 is displayed as determined from the line fit via equation 3.2 (black circles). In addition,
Rdia1 has been measured directly, so without gadobutrol, for different sucrose concentrations
(blue circles), showing that both lead to the same results. Even more interestingly is the
direct measurement of Rdia1 in D2O (gray circles). Instead of water, the sucrose is dissolved
by D2O. If only water protons would be measurable, one would expect a difference in the
results measured for sucrose in water. However, the results of Rdia1 obtained in water and
Rdia1 obtained in D2O led to comparable results. This is because the -OH groups of the
sucrose can chemically exchange their protons with D2O, leading to a situation, where water
contains also protons, not just deuterium. This chemical proton exchange, in addition to
the proton exchange via water diffusion, is very important for nanocapsules, as will be shown
later. In addition to the measurements, semi-empirical simulations with a home-written
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Matlab code were performed. Details of the calculations and its code can be found in the
experimental section 7.1.1. First, measurements were performed at a magnetic field of 4.7
T and a temperature of around 7 C. The calculations were performed for a magnetic field
of 4.7 T and 10 C. On the right side of Figure 4.4 the experimental results for r1, as well
as the simulated values for different sucrose concentrations are displayed. The higher the
sucrose concentration, the higher the viscosity. As expected the relaxivities change, but in a
Figure 4.4: Left: Diamagnetic relaxation rate Rdia
1
for the different sucrose concentrations as deter-
mined from the line fit (black), measured (blue) and measured in D2O (gray). Right:
Experimental relaxivity r1 (blue circles) and simulated relaxivity (blue dashed line) for
gadobutrol in a solution of water and sucrose, for different sucrose concentrations.
non-trivial way. Whereas up to 40 wt% sucrose the relaxivity increases, for 65 wt% it drops
to lower values. The simulation overestimates the experimental results by a factor of two.
However, it is able to describe the bending of the curve, the most important feature at this
point. To understand this behavior, it is helpful to look at the relaxivity of different water
exchange rates and rotational correlation times. On the left side of Figure 4.5 the relaxivity
for different values of the water exchange and the rotational correlation time is shown. On
the right side, the projection into the plane is shown. Red areas and blue areas correspond
to high and low relaxivities, respectively. In analogy to the island of stability for isotopes
one might call it an isle of high relaxivity. For gadobutrol, the water exchange time is 176
ns.71 It is also believed, that the water exchange is not influenced by changes in the envi-
ronment.74 And for Mn2+ solutions it has been shown, that even for sucrose concentrations
as high as 78 wt% the environment stays aqueous.75 Therefore one can assume that the
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Figure 4.5: Simulated relaxivity for gadobutrol in water for different water exchange and rotational
correlation times. Simulation is performed for 4.7 T and 283 K.
water exchange is unaffected by the presence of molecules other than water. The rotational
correlation time has been determined to be 57 ps.71 If one looks at Figure 4.5 and looks at
the relaxivity for the water exchange of 176 ns and the rotational correlation time of around
56 ps (Step 1, indicated by number one in a white circle, on the right Figure), one gets a
value of around three s 1mM 1, which is close to the measured value. If now, however,
the sucrose concentration is increased, and by that the viscosity, the rotational correlation
time is increased, whereas the water exchange rate stays the same (Step 2). The rotational
correlation time is shifted to higher values, which up to a few nanoseconds is beneficial. If
however the rotational correlation time is increased even further, the relaxivity starts to drop
to lower values (Step 3). This is why of the beginning in Figure 4.4 the relaxivity increased,
whereas for sucrose concentrations as high as 65 wt% the relaxivity dropped to a lower value.
In addition to changing the viscosity, one can also change the temperature. Since
fir / (T )
T
(4.16)
and if one assumes an Arrhenius behavior of the viscosity, with
(T ) / e 1RT (4.17)
the rotational correlation time gets smaller for increasing temperatures. In Figure 4.6 the
measured relaxivities for different sucrose solutions and different temperatures are displayed.
As one can see, the relaxivity for the 50 wt% sucrose decreases for temperatures higher
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Figure 4.6: Measured relaxivity for Gadovist in sucrose solutions of 50 wt% (black) and 65 wt% (blue)
for different temperatures.
than 293 K and for 65 wt% increases all the way up, until it is higher than for 50 wt%.
Again the relaxivity is simulated, this time dependent on the temperature and an increasing
sucrose concentration which is equivalent to an increasing viscosity. The result is shown
in Figure 4.7. The simulation shows a good qualitative agreement with the experiment. If
one looks at a temperature of 280 K, the relaxivity indeed first increases with increasing
sucrose concentration and then starts to decrease again if the sucrose concentration is too
high (As indicated by the white dashed arrow 1). This behavior was already observed in
Figure 4.4. If one now looks at the sucrose concentration of 50 wt% (White arrow 2) and 65
wt% (White arrow 3), and goes from 280 K to 310 K, one can again see the experimentally
observed behavior. For 50 wt% sucrose concentration the relaxivity decreases with increasing
temperature, whereas for 65 wt% the relaxivity steadily increases. Hence, the simulation is
able to describe the observed behavior qualitatively, even if the quantitative agreement is only
modest. The simulations, therefore, are able to give valuable hints as to which are the limiting
parameters. Because of the L-shape of the isle of high relaxivity, the rotational correlation
time leading to a high relaxivity has an optimum value. Though all experiments so far have
been performed at 4.7 T, the clinical standard field strength is still 1.5 T. Less than 20% of
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Figure 4.7: Relaxivity r1 for different temperatures and sucrose concentrations. Red areas correspond
to high relaxivities, blue areas to low relaxivities. Arrows are guide to the eye, details are
given in the text.
the MRI scanner works at 3 T and higher.76 Based on this fact together with the findings
described above, the magnetic field of the MRI scanner was changed from 4.7 T to 1.5 T.
In addition to that and to satisfy the physiological conditions, the temperature is set to 310
K, if not mentioned other. Again the relaxivity is simulated for different water exchange and
rotational correlation times in Figure 4.8. The major differences to the simulated relaxivity
Figure 4.8: Simulated relaxivity r1 for different water exchange times fim and rotational correlation
times fir , performed for 1.5 T and 310 K.
36
4 Results and Discussion
for 4.7 T are a higher total relaxivity and a very different shape of the isle of high relaxivity.
For the water exchange of 176 ns, there is no optimum value for fir anymore. An increasing
fir , leads in all cases to a high relaxivity, different to the situation at 4.7 T. Based on the
simulations one would expect, that the relaxivity for 1.5 T increases with an increasing fir .
Again the relaxivity is measured for different sucrose concentrations, but this time at a field
of 1.5 T and a temperature of 310 K. The experimental results together with the simulation
are shown in Figure 4.9. Very different to the case at 4.7 T, the relaxivity is now increasing,
Figure 4.9: Measured relaxivity r1 for different sucrose concentrations at 1.5 T and 310 K (blue
circles). The dashed blue line is the simulation, performed for 1.5 T and 313 K.
again like predicted by the simulation. It is hence possible, to tune the relaxivity in solution
in a controlled fashion and the simulations are able to give good qualitative agreements.
Since it is possible to control the relaxivity via the viscosity one can think about additives
other than sucrose. Therefore several different polymer solutions were tested, like poly(vinyl
alcohol) (PVA), dextran (Dex), poly(ethylene glycol) (PEG) for different wt% and different
molecular weights MW . Details can be found in the experimental section 7.1.2. The results
are displayed in Figure 4.10. As one can see, the relaxivity increases with the viscosity,
but in addition is very dependent on the investigated polymer. Therefore, different polymer
solutions with the same viscosities do not have the same relaxivities. Here, the concept
37
4 Results and Discussion
Figure 4.10: Relaxivities r1 for different polymer solutions of different wt% and different molecular
weight MW plotted against their measured viscosity.
of microviscosity comes into play. It is known, that the measured macroscopic viscosity in
heterogeneous solutions must not coincide with the microviscosity experienced by water.9,12
It has been observed for proteins in solution with water and dextran, that the diffusion
coefficient of the protein can become independent of the macroviscosity.77 This means, that
the local viscosity experienced by the protein is different to the measured viscosity, which
eventually impacts the diffusion coefficient. This is especially true, if the the cosolvent is
much larger than the investigated molecule. Therefore larger molecules like PEG or dextran
lead to a microviscosity very different to the macroviscosity. To demonstrate the effect of the
reduced viscosity, experimentally determined diffusion coefficients of water for the different
solutions and the diffusion coefficient calculated with the macroviscosity are displayed in
Figure 4.11. The experimentally determined diffusion coefficients are approximated from
measured values found in literature, see also section 7.1.2. The diffusion coefficients correlate
only weakly to the macroviscosity. The measured diffusion coefficients are much higher than
predicted, because the microviscosities are not as high as one would expect based on the
measured macroviscosities. To account for the reduced microviscosity, one can introduce a
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Figure 4.11: Diffusion coefficients of water, measured (black) and calculated (blue) for different
macroviscosities.
scalar value s between 0 and 1 to the macroviscosity, like
micro = s  macro (4.18)
where micro denotes the microviscosity and macro the measured macroviscosity. The





to account for the reduced viscosity experienced by water molecules. Of course the same is








A direct measure for the microviscosity is the diffusion coefficient, since D / 1=. Since
the diffusion coefficient in solution is measurable by NMR spectroscopy, one has a direct
measure for the microviscosity. Therefore, one can use the measured diffusion coefficient
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Figure 4.12: Measured relaxivity r1 (black), r1 simulated with macro (red), and r1 simulated with
micro (blue) plotted against the different measured macroviscosities. The dashed lines
are guides to the eye.
and perform a simulation with the calculated microviscosity. The result is shown in 4.12. The
simulations performed with the help of the microviscosity fit much better to the experimental
results than the simulations with the macroviscosity. This demonstrates, that indeed the
calculation with the macroviscosity leads to an overestimation of the rotational and diffusional
correlation time, leading to an overestimation of the relaxivity. And this is also the reason,
why sucrose turns out to be the best relaxivity enhancer among the investigated cosolvents,
since it is a smaller molecule, in comparison to PEG, Dex and so on.
4.1.3 High relaxivity in nanocapsules
Being able to adequately describe the relaxivity in solution, the focus of the next sections
is the relaxivity of encapsulated gadobutrol. The influence of encapsulation on the relax-
ivity has been investigated for several polyurea nanocapsule systems. All of the following
nanocapsule systems have been synthesized by Dr. Kerstin Malzahn, Max Planck Institute
for Polymer Research, Mainz.78 An overview is provided by Table 4.1. All systems are loaded
with gadobutrol in different amounts. The polymer shell is composed of 1,6-diamino hexane
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Table 4.1: Each column is: The used monomer, the gadobutrol concentration in the dispersed phase,
the amount of monomer, the amount of TDI, the size determined by DLS, and the co-
encapsulated substance, respectively.
Monomer cGd [mM] mMon [mg] mTDI [mg] Size [nm] Load
DAH 10 116 262 145  65 -
DAH 100 116 262 137  60 -
DAB 10 88 262 175  24 -
DAB 100 88 262 166  20 -
DAE 10 60 262 181  33 -
DAB 10 88 262 190  20 sucrose
(DAH), 1,4-diamino butane (DAB) or 1,2-diamino ethylene (DAE) and 2,4-toluene diiso-
cyanate (TDI). If not mentioned other, the ratio of the used diamine to TDI is always 1:1.5
and the initial concentration of gadobutrol in the dispersed phase is 10 mM. The concen-
tration of gadolinium has been determined via Inductively Coupled Plasma Optical Emission
Spectroscopy (ICP-OES). The nanocapsules are redispersed in water. The capsules will be
named according to their used diamine. For example, capsules prepared from DAB in a
ratio 1:1.5 TDI, with an initial concentration of gadolinium of 10 mM, will simply be named
DAB-NC and so on. If anything is changing like the concentration or the ratio of monomer
to TDI, it will be mentioned explicitly.
As mentioned, there are dozen of different attempts to tune the relaxivity to higher values
than those of low molecular weight contrast agents. One approach is to encapsulate contrast
agents, which then experience restricted diffusion.64,66,79 However, only a few attempts have
been made to theoretically describe this behavior.80 Molecules which are confined in a closed
environment will have a diffusion coefficient different to that in bulk, because of interactions
with the confining system.81 That effectively reduces the diffusion, which gives rise to a
prolonged fiD, which again leads to high relaxation rates as already observed for relaxivity
measurements in highly viscous solutions. This situation is sketched in Figure 4.13. An
easy experiment to find out, if really the diffusion or rotation is restricted, is to measure
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Figure 4.13: Left: Sketch of gadobutrol complexes in solution and the most important parameters,
fim, fir and fiD. Right: Sketch of gadobutrol complexes in a nanocapsule. The Diffusion
changes because of interactions with the polymer shell, which slows down the diffusional
correlation time fiD which is marked red. The proton exchange from the bulk to the
inner of the capsule is referred to as fin.
the relaxivities at high field, see Figure 4.14. The relaxivity is dramatically decreased at
Figure 4.14: Relaxivities r1 for different capsule compositions at 64 MHz (blue) and 300 MHz (black).
high field. Since the gadobutrol complex is unchanged, one can easily consider the same
42
4 Results and Discussion
parameters to be important as in the case of gadobutrol which is not encapsulated. Apart
from the parameters that are constant or are not influenced by the encapsulation process, the
important parameters are the water exchange fim from inner sphere to bulk, the electronic
relaxation time T1;e , the rotational correlation time fir and the diffusional correlation time
fiD. The water exchange is a field independent term and can therefore not be responsible for
the decrease. The electronic relaxation time T1;e is field dependent. This is a good point to
recapture what actually determines the relaxivity in the end. Relaxivity is proportional to the






















where the parameters have the meaning as defined in chapter 2. The overall correlation time
fic is dominated by whichever is the shortest time of T1;e , fim or fir . Like already mentioned
the important thing here is that the spectral density function and hence relaxivity will increase
with increasing fic till the point where !2I fi
2




c gets larger than
one, the relaxivity starts to decrease again. Therefore it is beneficial to prolong the correlation
time fic but only up to a certain point. For gadobutrol in water fir is on the order of some
tenth of picoseconds, whereas T1;e is in the area of some ns.52,56,71 As T1;e is increasing
quadratically with the magnetic field strength, it is only important at low magnetic fields and
becomes less important with increasing field strengths.52 This results in fir being the most
important parameter to increase in case of the inner sphere relaxation. One can make similar
considerations for the outer sphere relaxation rate, in which then fiD turns out to be the
most important parameter. Eventually, only fir and fiD are left over, which can give rise to
such a large relaxivity, without any further gadobutrol complex modification. However, as the
gadobutrol complex is not modified but just encapsulated, the rotational correlation should
not differ too much. To support this argument, 17O measurements were performed. For
low molecular weight contrast agents, like gadobutrol, 17O measurements can independently
reveal most of the important parameters like the rotational correlation time.71 It has been
found, that for 17O the longitudinal relaxation is dominantly inner sphere in nature and that
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Table 4.2: T1 times of










298 6.9 n.a. 6.7 n.a.
303 7.9 7.8 7.6 7.5
308 8.9 n.a. 8.5 n.a.
313 9.9 9.8 n.a. 9.2
318 11.2 n.a. 10.3 n.a.
323 12.2 11.7 11.3 11.2
333 14.7 14.1 13.7 13.2
the outer sphere contribution can be neglected.82 If fir is much shorter than fim and T1;e ,
the inner sphere relaxation rate will simply be proportional to fir , e.g. R
17O
1 / fir .83 A R
17O
1
measurement has been performed at 700 MHz, for which the electronic relaxation time can
be calculated to be 0.2 s. The water exchange is for gadobutrol already on the order of 0.15
s and even longer for encapsulated gadobutrol, as will be shown later. Hence, the condition
fir  T1;e ; fim is easily fulfilled. Since fir is a function of temperature, one can determine the
rotational correlation time via a fit of the longitudinal relaxation rates acquired for different
temperatures. However, in case of the capsules, no significant difference in T1 for neat H2O17
and different capsule compositions has been found for different temperatures, see Table 4.2.
In all cases, the change is less than 10%. That means, the inner sphere contribution is
negligible, which in turn means that it is not the rotation which is diminished or at least not
as much as would be necessary to explain the sixfold increase of relaxivities in nanocapsules.
The same observation has been made for gadofullerenes, for which the T1 relaxation of 17O
was found to be within a margin of 15% for the gadolinium loaded fullerenes in comparison
to water. Since water cannot penetrate into the fullerene cage, there is no inner sphere
contribution. Instead and like expected an outer sphere contribution was proposed to be the
source of high relaxivity.16,84
That leaves the diffusion which gives rise to a longer fiD and hence higher r1. In order to
further investigate the diffusion, DOSY measurements have been performed on DAB-NC
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without gadobutrol. If the water exchange is slow enough, one would expect at least two
contributions: One coming from the inside of the capsule, experiencing restricted diffusion
and one coming from the bulk phase. To prevent that the result is influenced by proton
exchange, the measurement was performed on 17O enriched H2O17. The result is shown
in Figure 4.15. Again, there is no observable second component. With a mono-exponential
Figure 4.15: DOSY measurement on DAB-NC in H2O
17. Red line is the fit with equation 3.3.
fit the curve is well described. Since the diffusion time in the sequence is on the order
of some ms, the fast exchange makes it impossible to measure two separated diffusion
coefficients. Instead, the water molecules experience different kind of environments within
the given diffusion time, which gives rise to an averaged diffusion coefficient. To get a
direct experimental proof that indeed the diffusion is restricted, NMRD measurements on
DAB-NC without gadobutrol have been performed (Figure 4.16) by Dr. Oliver Neudert at the
University of Ilmenau. Interestingly the relaxation rate decreases rather slowly. For freely and
isotropically diffusing water, one would expect a ! 2 dependency. However, in this case, a
power function with R1 / !  could be fitted, where   0.46. This behavior could fit with
a relaxation model called Reorientation Mediated by Translational Displacements (RMTD).85
It was found, that in this case  is 0.50  0.04, which matches within the error with the
value found here. The key point in this model is, that the molecules under investigation,
e.g. water, are not freely diffusing anymore, but temporarily bind to a solid matrix. The
solid matrix here would be the polymer shell of the capsule. Though it is not entirely clear,
if really the RMTD mechanism is responsible for the altered relaxation behavior, the water
dynamics in the nanocapsules are definitely slowed down in comparison to water in the bulk
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Figure 4.16: 1H relaxation rate for different Larmor frequencies for DAB-NC.
phase. Eventually for the NCs this gives rise to a strong outer sphere effect and therefore to
the increased relaxivity.
Thinking about medical applications, one should keep in mind, that in fact the total re-
laxation rate is more interesting than just the relaxivity. Since the total relaxation rate is
proportional to the relaxivity in product with the gadolinium concentration, a low relaxivity
can be counterbalanced by a high concentration and vice versa. Therefore, the influence of
the gadolinium loading on the relaxivity is investigated. For that, different capsules have been
synthesized, with an initial concentration of gadobutrol in the dispersed phase of 10 mM and
100 mM, respectively. The investigated systems are DAH-NC and DAB-NC. The relaxivities
are shown on the left side of Figure 4.17. The first thing one notices is the dramatically
increased relaxivity, depending on the monomer used in comparison to neat gadobutrol in
water. This relaxivity increase will be discussed below. Furthermore the relaxivity decreases
for increasing gadobutrol loading in the capsules. This behavior has already been observed
in literature.68,86 To further elucidate the origin of this observation, one can measure the
relaxivity for high concentrations in solution, see right side of Figure 4.17.
As one can see, even for concentrations as high as 100 mM, the highest concentration used
for gadobutrol in the dispersed phase, there is almost no deviation from the linear behavior
known for low concentrations. This shows that the drop in relaxivity is not an intrinsic effect
for high concentrations of gadobutrol, but rather a special characteristic of nanocapsules.
Figure 4.18 shows the difference between the two different situations of nanocapsules with
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Figure 4.17: Left: Relaxivity r1 for different compositions of the nanocapsule system. DAH and DAB
stand for the investigated systems DAH-NC and DAB-NC, respectively. The number
stands for the gadobutrol concentration in the dispersed phase in Mol. Right: Relaxation
rate R1 of gadobutrol in water for high concentrations.
a low and high loading of gadobutrol, respectively. In Figure 4.18 a.) the capsule has a
Figure 4.18: Sketch of capsules (black dashed circle) loaded with gadobutrol (green and red squares).
Green squares correspond to active gadobutrol complexes, red squares to inactive
gadobutrol complexes. Blue circles indicate water, red circles stand for water which
is already relaxed. The gray dashed circle in the middle is to ease the visualization. The
case of low loading correspond to situation a.), the capsule with high loading to situation
b.).
low loading of gadobutrol. Water protons, that exchange through the polymer shell of the
capsule are effectively relaxed by gadobutrol complexes at the surface. These complexes will
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for now be called active complexes. Some gadobutrol complexes however, will only "see"
water molecules which have been already relaxed (red circles). Therefore, these gadobutrol
complexes are not contributing to the relaxivity, since they do not relax any water which
has not been relaxed before. They will be referred to as inactive complexes. In case of the
situation in Figure 4.18 b.) the loading of gadobutrol is increased in comparison to Figure
4.18 a.). In this situation, even more gadobutrol complexes are inactive. The situation is even
worse for the capsules, since the relaxivity is increased. This means, the gadobutrol complexes
at the inner surface of the capsule will relax incoming water molecules very effectively. This
in turn decreases the chance for gadobutrol complexes in the inner part of the capsule to get
in contact with water which has not been relaxed. From the point of view of the relaxation
rate, these complexes do not exist, hence the conventional formula R1 = Rdia1 + r1  [c ] would
actually be written as
R1 = R
dia
1 + r1  ([c iact ] + [c iinact ]) i 2 f10 mM; 100 mMg (4.24)
[c iact ] is the concentration of active gadobutrol complexes, [c
i
inact ] is the concentration of
inactive complexes for 10 mM and 100 mM respectively. Since only the active gadobutrol
complexes contributing to the relaxivity, the measured relaxation rate will be
R1 = R
dia
1 + r1  [cact ] (4.25)
which is equal to
R1 = R
dia
1 + r1  ([c ]  [c iinact ]) i 2 f10 mM; 100 mMg (4.26)
Since c100 mMinact > c
10 mM
inact , the measured relaxation rate R1 will be decreased and hence the
calculated relaxivity r1.
Having discussed the difference between capsules with 10 mM and 100 mM loading, one
should continue with the difference between DAH and DAB capsules. The major difference
between these two compositions is the number of urea bonds in the polymer shell. It is known
that -NH2 and -OH groups can chemically exchange protons.42,87 The exchange rate can
be higher than 104 s 1.88 This represents an effective means of proton transfer, without the
need to exchange a whole water molecule by diffusion through the polymer shell.89 Because
protons of the polymer shell will have a decreased mobility, they will have a decreased T2
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time.87 To test this, DAB-NC capsules have been synthesized without gadobutrol, to see
to which extent the T1 and the T2 time are affected by the presence of the polymer shell
alone, see Figure 4.19. Though the capsules are without gadobutrol, they are related to a
gadolinium concentration. Details can be found in section 7.1.3. The first observation is
that R1 is barely affected by the polymer shell alone. On the other hand R2 is influenced
significantly. The relaxivities for the polymer shells are rdia1 = 0.3 s
 1mM 1and rdia2 = 10.3
s 1mM 1. This means that the diamagnetic contribution is concentration dependent rather





i  [c ] + ri  [c ] i 2 f1; 2g (4.27)
where rdiai has been introduced, a diamagnetic relaxivity due to the presence of the nanocap-
sules.
Figure 4.19: Left: Relaxation rates R1 (black) and R2 (blue) for DAB-NC for different gadolinium
concentrations. Right: Relaxivities r1 for Gadovist, DAH-NC, DAB-NC and DAE-NC
respectively.
In order to further investigate the influence of the nanocapsules on the relaxivity, nanocapsules
with DAE have been prepared and the relaxivities are shown on the right side of Figure 4.19.
Since the number of -NH groups is increasing with the number of urea bonds, the DAB
capsules can exchange more protons than DAH capsules. To further test this assumption,
capsules with DAE have been prepared, which increases the density of urea bonds even
further. On the right side of Figure 4.19 one can see that the relaxivity increases with the use
of DAE in comparison to DAB and DAH like expected. Hence, the relaxivity of the capsules
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would be higher, if the proton exchange would be faster. This indicates, that the gadobutrol
in the capsules could relax even better if the proton exchange would be higher. Moreover,
the transverse relaxivity increases non-linear. To emphasize these results, one can look at
the relaxivity for different temperatures. The change in temperature has two consequences.
On one hand fir and fiD are becoming shorter with increasing temperature. On the other
hand, the proton and water exchange rate increases with increasing temperature, see left
side of Figure 4.20. A decreasing relaxivity with increasing temperature indicates a system in
which the water exchange is fast enough. If the temperature leads to an increase in relaxivity
then the water exchange is the limiting factor. The relaxivity for different systems and
temperatures is shown on the right side of Figure 4.20. For gadobutrol the relaxivity decreases
Figure 4.20: Left: Diffusional correlation time fiD (blue line) and water exchange time fim (black line)
for different temperatures. Right: Relaxivity r1 for DAE-NC (red triangles), DAB-NC
(blue squares) and DAH-NC (black circles) and neat gadobutrol (green hexagons).
with increasing temperature, as mentioned above, this indicates a fast exchange system.
In comparison, three nanocapsule systems have been investigated, namely DAE-NC, DAB-
NC and DAH-NC and for all of them the relaxivity increases with increasing temperature,
as expected for systems slowly exchanging protons. However, for the DAE capsules, the
relaxivity increases from 293 K to 320 K by only 17%, for DAB by 26% and for DAH by
more than 70%. This shows, that for DAH capsules, the relaxivity is quenched because of
the slow proton exchange. These findings can be compared to observations of polymersomic
systems, for which it has been found, that the relaxivity can be tripled, if water permeation
through pores in the polymersomes is enabled.90
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4.1.4 Increasing relaxivity by co-encapsulation
In the last sections, it was shown, that sucrose can enhance the relaxivity by some orders
of magnitude. Furthermore, it has been demonstrated, that the relaxivity can be increased
by encapsulation and the resulting change in water molecules diffusion. To combine the
beneficial effects, the versatility of nanocapsules has been used to not only encapsulate
gadobutrol, but in addition sucrose in DAB-NC.78 This situation is sketched in Figure 4.21.
It has been shown, that the sucrose molecules are distributed within the capsule, rather than
being attached to the inner surface of the capsule.78 Hence, one can assume, that the sucrose
within the capsule has the same effect as in solution. On the right side of Figure 4.21, the
relaxivity for capsules with co-encapsulated sucrose is plotted in comparison to other capsule
compositions. As shown, the relaxivity increases up to a value of 28.6 s 1mM 1, which
Figure 4.21: Left: Sketch of a nanocapsule, with co-encapsulated sucrose (white hexagons). Because
of the encapsulation of viscous sucrose, fir and fiD in the interior changes. Right: Relaxiv-
ity of capsules with sucrose encapsulated in comparison to NC without co-encapsulation.
corresponds to a ten-fold increase in relaxivity in comparison to gadobutrol in water alone.
Therefore sucrose has the anticipated effect.
4.1.5 Exchange of water in and out of nanocapsules
As already said, the water exchange from the bulk phase to the inner sphere of the gadobutrol
complex is of the utmost importance. To transfer the relaxation effect of the paramagnetic
center to the bulk phase outside the nanocapsule, it is equally important to have a fast water
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exchange from the bulk phase to the interior of the nanocapsule and vice versa. For low
molecular weight contrast agents, 17O T2 measurements have been shown to give analytical
access to the water exchange fim from the inner sphere to the bulk.71,91 The advantage
of 17O is that, unlike 1H it cannot chemically exchange. Hence, in opposition to 1H-NMR,
one tracks the whole water molecules and not just the single protons. The 17O transverse
relaxivity for Gd3+ complexes is in contrast to 1H relaxation very dependent on the scalar
contribution. That is because 17O is directly bound to the Gd3+ center, which makes the
scalar interaction much stronger than in case of protons, since in the latter case it is mediated
over two bonds. For long electronic relaxation times, e.g. !20T
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in which the parameters have their usual meaning but for 17O, hence S = 5/2 and A
~
=
-2.810 6.71 Since fim is temperature dependent, the water exchange can be obtained via
temperature dependent T2 measurements. The outcome of such a measurement is displayed
on the left side of Figure 4.22, for which the relaxivity has been measured for a solution
of gadobutrol in water. To make sure that the electronic contribution is negligible, the
measurement has been performed with an external magnetic field of 700 MHz, for which the
electronic relaxation time can be calculated to be on the order of hundreds of nanoseconds.
The condition !20T
2
1;e > 1 is then easily fulfilled. As one can see, the relaxivity first increases
with temperature up to a certain point, at which fim is short with respect to T2;m and
hence dominates the expression in equation 4.28. Beyond this point, the relaxivity decreases
again. The region before the crossover is the so called slow exchange regime. In this region
the relaxivity is determined and limited by slow water exchange. In this area, the relaxivity
increases, because with increasing temperature the water exchange gets faster, which in this
case is beneficial. After the crossover, the relaxivity decreases with temperature. That is
because the water exchange is too fast and 17O is not sufficiently relaxed anymore. The data
points have been fitted with equation 4.28 and for 310 K a water exchange of fim of 409 
73 ns has been obtained, which is above the literature value of 176  21 ns.71 However,
the result is at least the right order of magnitude and considering that only four data points
have been acquired and that the confidence interval is rather broad, the result is fair. On
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the right side of Figure 4.22, the results for the same measurement are shown but this time
for nanocapsules. The relaxivity increases with temperature for all systems, as also indicated
Figure 4.22: Left: Relaxivity r2 for
17O for different temperatures and capsule compositions. The
errors are calculated via Gauss error propagation, under assumption of a 5% error on the
T2 measurements. The green/blue dashed line for the left diagram indicates the 95%
confidence interval, the red curve is the fit to the data points. Right: Same measurement
for DAH-NC (red squares), DAB-NC (blue circles) and DAE-NC (black triangles). Lines
are linear fits to the data points.
by the line fits. That indicates, that the encapsulated gadobutrol is in the slow exchange
regime. For none of the systems was the changeover to the fast exchange regime observed.
Also one can state, that within the assumed error, the capsules have around the same time
for the water exchange. This demonstrates, that the exchange of whole water molecules is
not too different for different systems. If protons would only be exchanged via the whole
water molecule, the slow exchange would probably quench the relaxivity.
One should recapture, that in clinical MRI one actually looks at the protons of the water
molecules rather than the oxygen. Therefore it is important to have a fast proton transfer,
for instance via chemical exchange. The time constant for the water exchange from the bulk
to the interior of the capsule will be denoted as fin, as already introduced in section 3.5, see
Figure 4.23. If one imagines a capsule which can not exchange protons with the bulk phase,
the protons in the interior will be relaxed immediately after encapsulation of the gadobutrol.
However, by that only very few protons can be relaxed whereas the bulk remains completely
unaffected and has the relaxation rate of pure water. Therefor one has to counterbalance the
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Figure 4.23: Water exchange from the bulk phase to the interior of the capsule fin and exchange from
the interior to the inner sphere of the gadobutrol denoted as fim.
permeability of the capsule to water or protons, whereas at the same time, the gadobutrol
complex should stay encapsulated. Like already mentioned in chapter 3.5 there are several
NMR sequences to measure the water exchange from bulk phase to the inner of the capsule,
like DEXSY or ARTDECO. In Figure 4.24 ARTDECO has been measured for two physically
separated solutions of water and CuSO4 and neat ethylene glycol (EG). The system therefore
has two components, with two different T2 times. On the left side of Figure 4.24 one sees
the experimental result, in the middle the two dimensional fit and on the right side, the
deviation di of the fit from the experimental result, which is simply given by
di = S
exp
i   Sf iti (4.29)
where Sexpi is the signal intensity in the experiment and S
f it
i the signal intensity of the fit for
a given point i . As one can see, is the deviation at nearly all points in the green area, which
corresponds to zero percent. Hence, the experimental result is well described by the fit. In
Figure 4.24: Experimental result for ARTDECO for two physically separated solutions of water and
EG (left), fit of the experimental result (middle), and the percentage deviation% (right).
Table 4.3 the result from the fit is summarized. To have a measure for the overall quality of
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Since the systems are physically separated, there is no exchange at all. Therefore, the
Table 4.3: Parameters obtained from 2D fit on the ARTDECO results.
fin [ms] a11[a:u:] a12 [a.u.] a21 [a.u.] a22 [a.u.] ff
1 53 0 0 50 0.17
measurement has been performed for only one exchange time fin of 1 ms. As expected for
two physically separated samples of equal volume, one gets two components a11 (water)
and a22 (EG) of equal size and no exchange components a12, which would correspond to an
exchange of the reservoir of water to that of EG. In the same way a21 is zero.
Now, DAB-NC are measured but without having gadobutrol encapsulated. The reason is
the much too short T2 time of water within the capsule, if gadobutrol is encapsulated,
which makes it then difficult to measure a T2 time. For nanocapsules it is beneficial to use
ARTDECO instead of DEXSY, since T2 is easier to measure and in opposition to diffusion
measurements does not destroy the signal. The results are shown in Figure 4.25. Again is on
the left side the experimental result, in the middle the two dimensional fit and on the right
side the deviation in percent of the fit from the experimental result. The experimental result
is well described by the fit, as the right plot of Figure 4.25 is predominantly green.
The parameters obtained from the two dimensional fit of the experimental results are shown
in Table 4.4. The experimental results are well described by the fit. The deviation is close to
zero in all cases. There is a very predominant component a22 for all exchange times, whereas
all the other components are almost negligible, especially the exchange components a1;2 and
a2;1. The difference for fin of 100 ms is because this exchange times is on the order of the T2
time. Therefore, the signal has decayed already, which leads to big uncertainties, indicated
by a ff threefold higher than for the other exchange times. Apart from that and even more
important, there is almost no difference between the different exchange times. As already
55
4 Results and Discussion
Figure 4.25: Experimental result for ARTDECO with an exchange time of 100 s (left), fit of the
experimental result (middle), and the residuals (right).
Table 4.4: Parameters obtained from 2D fit on the ARTDECO results.
fin [ms] a11[a:u:] a12 [a.u.] a21 [a.u.] a22 [a.u.] ff
0.1 8 3 3 95 0.17
1 10 5 0 98 0.14
5 10 4 0 100 0.14
10 12 4 0 99 0.17
100 1 2 12 100 0.55
mentioned in chapter 3.5, if only one component is measured, this can have two meanings:
Either no exchange at all, or an exchange which is so fast, that only an averaged component
is measured. The first option is impossible, because that would lead to capsules without any
relaxation effect. This is not true as will be shown. The other option means the protons have
exchanged already completely and experienced all environments. Then only one component
is measured. That indicates, that the exchange must not be slower than some hundred
s. To reinforce the result, another experiment was performed. This time, the capsules
are redispersed not in water but in neat Gadovist. The signal from water molecules, which
exchange from the capsule to the bulk phase will immediately decay because of the extremely
high relaxation rate of Gadovist. Hence, the signal in the bulk phase is completely suppressed.
If the water exchange would be slow, one would only see the signal coming from the interior
of the capsules. Because the signal decay in Gadovist is too fast, no T1 or T2 relaxation
times are measurable, which has been confirmed experimentally. One can only estimate, if
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the relaxivity is the same as for low concentrations, that the relaxation rate in the one molar
Gadvoist solution is around R1  r1  [c ]  5600 s 1mM 1, the R2 rate is in the same order
or even higher. Under the assumption, that T1  T2 = 1=R2  T 2 = 1=(5600s 1mM 1) 
180 s, the FID in this solution will decay at around three times T 2 , hence 550 s. The
FID after accumulation of 4096 scans of pure Gadovist and capsules with water inside and
Gadovist in the bulk phase are shown in Figure 4.26. The FID for the neat Gadovist solution
Figure 4.26: FID for 1 molar Gadovist solution (left) and for nanocapsules with water inside and 1
molar Gadovist as bulk phase (right). The gray dashed box indicates the dead time.
decays within some hundred s, like expected. Because of the dead time, no signal decaying
faster than 300 s is recordable. The same experiment with the nanocapsules, gives the same
result. The signal again decays on the order of hundreds of s. Under the assumption, that
the exchange is for example on the order of some ms, one would expect two components:
One component coming from the water inside the capsule, and another component from the
Gadovist outside, which again decays rapidly. Therefore, this experiment goes along with the
exchange measurement ARTDECO. In both cases, one can only give an upper limit for the
exchange of protons, which must be on the order of, at maximum, some hundreds s.
4.1.6 In vivo imaging
To test the performance of the nanocapsules as contrast agents, imaging experiments have
been performed in vitro as well as in vivo. The nanocapsules are DAB-NC capsules, but with
an initial gadolinium concentration of 100 mM in the dispersed phase. As seen above, the
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relaxivity for capsules with an initial loading of 100 mM is lower than for 10 mM. In this
case, the relaxivity r1 is 11.4 s 1mM 1, whereas the same capsules with 10 mM loading
have an r1 of 15.9 s 1mM 1. However, the total gadolinium concentration in the first case
is around 1.5 mM whereas in the latter it is around 0.5 mM. Hence, for the 10 mM capsules
R1 = R
dia
1 + r1  [c ] = 0.23 s 1 + 15.9 s 1mM 10.5 mM = 8.18 s 1, whereas in the case
of 100 mM capsules it is R1 = 0.23 s 1 + 11.4 s 1mM 11.5 mM = 17.3 s 1. Hence, the
low relaxivity is counterbalanced by a higher total gadolinium concentration, resulting in a
higher total relaxation rate. To be compatible with physiological conditions, the capsules
have been redispersed in a 0.9 wt% NaCl solution for which the T1 and T2 time was found
to be comparable to neat water (data not shown). The in vitro results are compared to 1
wt% agarose, which is known to mimic T1 and T2 times that can arise in vivo.92,93 As a
control, pure water has been imaged too. The results of the in vitro experiments are shown
in Figure 4.27. The solution with nanocapsules appears very bright in comparison to the 1
Figure 4.27: Left: Coronal view for solutions of DAB capsules in a ratio 1:1.5 to TDI and a gadolinium
loading of 100 mM, agarose and neat water. Right: Signal intensity in three dimensions.
The sequence was a spin echo sequence with a repetition delay of 300 ms and an echo
time of 8 ms.
wt% agarose and even brighter in comparison to water. In fact, only if the signal intensity
is shown in three dimensions, like done on the right side of Figure 4.27, one is able to
identify the water signal at all. In the sequence, a short repetition delay of 300 ms has been
chosen to obtain a T1 weighted image. This prevents the slowly relaxing agarose and water
from recovering their thermal magnetization and gives rise to a diminished signal intensity.
In opposition to that the nanocapsule solution has an R1 of 17.3 s 1, which equals a T1
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time of 55 ms. Hence, the 300 ms are sufficient to fully recover the magnetization, which
eventually leads to the bright signal. Though the in vitro experiments are very promising, the
conditions that arise in vivo are very different. The blood interacts with the nanocapsules in
a very different way than water, the capsules flow in the blood stream and must withstand
shear forces and macrophages can take up nanocapsules which can slow down the water
exchange. These are just few examples which can change the relaxation behavior in a way
that is hardly influenceable. Therefore, in vivo experiments must demonstrate the benefit of
encapsulated gadobutrol and that the nanocapsules are working in the anticipated way. For
the experiments, a C57BL/6 (B6, or black 6) laboratory mouse was used, with a total weight
of around 26 g. The images have been acquired by Dipl. Ing. Andrea Kronfeld (University
Medical Center, Mainz). The first image 4.28 is the coronal view of the mouse. On the
left side is the mouse before the nanocapsules have been injected into the tail vein. On the
right side approximately 15 min after injection of the nanocapsules. The tail vein shows up
Figure 4.28: MR image of a mouse in coronal view. Left side prior to injection of nanocapsules, right
side post injection. Red dashed circle mark the vein.
intensely after the nanocapsules have been injected. It is even possible to see smaller blood
vessels, which are barely visible in the native image. In the next plane of the coronal view,
the heart shows up, see Figure 4.29. The heart also is much brighter after the nanocapsules
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Figure 4.29: MR image of a mouse in coronal view. Left side prior to injection of nanocapsules, right
side post injection. Red dashed circle highlights the heart.
have been injected. The images nonambiguously demonstrate that the nanocapsules can
work as contrast agents. Since the signal intensity is directly correlated to the position of
the nanocapsules one can see where the capsules are going to with time, see Figure 4.30.
The signal intensity has been analyzed for different times and areas of the body, for details
see the experimental section 7.1.4. At time zero, one has an intensity of 25 in arbitrary
Figure 4.30: Signal intensity in different region (Heart [red diamond], vein [black circles] and liver
[green squares]) for different times.
units for the vein and the heart and around 50 for the liver. Five minutes after injection, the
intensity at the vein has increased threefold and for the heart fourfold. That corresponds
approximately to the situation already observed in the in vitro experiments. For the liver,
the increase is not that high, probably because the time of observation is too short to see
the nanocapsules accumulating. Unfortunately the mouse died approximately 20 min after
injection because of an erroneous anesthesia.
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4.2 Negative contrast agents#
Having discussed positive contrast agents in the last section, this section is about T2 contrast
agents. It starts with a short introduction to the investigated systems. Then the theory
behind transverse relaxivity will be introduced and used to explicitly calculate the transverse
relaxivity. Afterward, a second approach to predict transverse relaxivities will be introduced,
which is especially helpful for nanocapsules. Subsequently, the last subsection compares and
evaluates the results gained by the two different approaches.
4.2.1 Introduction of the systems
All systems have been prepared by Dr. Markus Bannwarth.24,95 In total ten different T2
contrast agents are investigated, which can be divided into three groups. The first group are
single SPIOs with different diameter, namely 8  1 nm, 16  3 nm and 20  4 nm. The
second group are nanoparticles of diameter 146  39 nm and 156  46 nm, see Figure 4.31.
Both NPs are loaded with 8 nm SPIOs.The last group are nanocapsules with diameter of 250
Figure 4.31: Transmission Electron Microscopy (TEM) image of NP-156.
#This section in parts is based on the publication "How Morphology Influences Relaxivity - Comparative
Study of Superparamagnetic Iron Oxide/Polymer Hybrid Nanostructures" by Sandro Ebert, Markus B.
Bannwarth, Anna Musyanovich, Katharina Landfester and Kerstin Münnemann in Contrast Media and
Molecular Imaging, 201594 and on the publication "Tailor-Made Nanocontainers for Combined Magnetic-
Field-Induced Release and MRI" Markus B. Bannwarth, Sandro Ebert, Maximilian Lauck, Ulrich Ziener,
Stephanie Tomcin, Gerhard Jakob, Kerstin Münnemann, Volker Mailänder, Anna Musyanovych and Katha-
rina Landfester in Macromolecular Bioscience, 2014.24
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 76 nm, which are loaded with 10 nm SPIOs, 400  121 nm loaded with 20 nm SPIOs and
three nanocapsules with a diameter of 200  51 nm, which are loaded to different amounts
with 16 nm SPIOs, see Figure 4.32.24 All of the systems are named according to their
Figure 4.32: Left: TEM image of NC-200-H. Right: Scanning Electron Microscopy (SEM) image of
NC-400.
morphology and diameter, hence S-8, S-16 and S-20 for the 8 nm SPIO, the 16 nm SPIO
and the 20 nm SPIO, respectively. In the same way, the nanoparticles are called NP-146
and NP-156 and the nanocapsules NC-250 and NC-400. The nanocapsules loaded with S-16
SPIOs will be called NC-200-L, NC-200-M and NC-200-H, where L stands for the lowest,
M for a medium and H for the highest loading with S-16 SPIOs, respectively. Please note,
that in the given reference, NC-200-L, NC-200-M and NC-200-H are named VA-060-Low,
VA-060-Med and VA-060-High, respectively. For all systems, the longitudinal relaxivity r1 is
smaller than 2 s 1mM 1 (data not shown). As already mentioned in the theoretical section,
R1 decreases for too long correlation times, see also Figure 2.3 in section 2.1. This leads to
an often observed low r1 value.25,96 For example, Ai et al. found magnetite loaded micelles,
which have an r2 as high as 471 s 1mM 1, but for the same system an r1 as low as 2
s 1mM 1.97
4.2.2 Theory and simulation of transverse relaxivity
The relaxation rates of the introduced systems can be simulated in a semi-empirical approach.
To analyze the nanoparticles and nanocapsules, they were assumed to behave as clusters of
SPIOs. They are treated as weakly magnetized particles, like is common in literature.98
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This is sketched in Figure 4.33. To prevent the SPIOs from agglomeration, they are coated
Figure 4.33: Different NP and NC morphologies (1,2 and 3) and how they are included in the sim-
ulation (4). Blue spheres stand for water, orange spheres for iron oxide particles, black
dashed circles for the polymeric shell, green areas for polymeric material.
with oleate, which is estimated to result in an 1 nm layer around the SPIO. Hence, the
magnetic field felt by the water molecules diffusing near the SPIO is effectively reduced.99
The SPIO then behaves like a weakly magnetized sphere, which has a larger effective radius
of r ef fSP IO = rSP IO + d where rSP IO denotes the radius of the iron oxide core and d the
coating thickness. Because there is no formalism to explicitly consider the coating of SPIOs
or the polymer shell around NPs, the hydrodynamic radii experimentally determined by DLS
have been used for the simulations. In principal the inner and outer sphere relaxivity theory
depicted for T1 contrast agents also holds true for negative contrast agents. But the inner
sphere contribution is negligible in comparison to outer sphere contributions.10
Even more important is an effect experimentally observed by Josephson et al. but not pre-
dicted by SBM theory and the Freed model.25 According to Josephson the relaxivity of
iron oxides first increases with the particle size, but above a certain level starts to decrease,
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whereas the SBM theory and Freed model predict a steadily increasing relaxivity with in-
creasing particle size. The experimental observations of Josephson have been underlined by
Monte Carlo simulations of a group in Belgium.26 Roch, Gillis, Muller, Brooks et al. derived
a set of equations feasible to describe the observed behavior.26,60,100103 An overview can
be found in a recent review.10
The iron oxide containing nanoparticle is considered as a large magnetized sphere, with a
total magnetic moment growing according to Langevin's law
M = NspL(x) (4.31)
with N being the number of iron oxides per particle, sp the magnetic moment of one iron
oxide, L(x) the Langevin function






In equation 4.33 sp denotes the magnetic moment of one elementary iron oxide crystal.
Before making the next steps, one defines !, the difference in Larmor frequency between





with M being the particle magnetization. The relaxation behavior is now divided in three
regions:10,102
1.) Motional averaging (MA) regime in which are mostly small nanoparticles. For theses small
nanoparticles, the magnetic field is averaged to zero by the diffusion of the water molecules
around the particle.58,59,102 To fall into this regime, nanoparticles must fulfill !fiD < 1,
with fiD the diffusional correlation time like defined in equation 4.12. The relaxation rate
then is given by
R2 = 16=45  fA!2fiD (4.35)
All parameters are denoted like above. In the motional averaging regime T2 equals T 2 . That
is because fiD is much shorter than usual echo times of some hundred s . Refocusing pulses
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are inefficient then, because the environment of a particle changes faster than the refocusing
pulse can rephase the spins.





true. The static dephasing regime originally was introduced by Brown.104 He assumed
uniformly distributed and motionless magnetic grains, which do not affect each other. These





x1=3(1:52 + fNP x)
5=3 (4.36)
and x = !tE=2, tE the echo time between two 180 pulses in a CPMG echo train, and fNP
the volumetric fraction between nanoparticles and solution. R2 then is given by






3.) The so called echo limiting (EL) regime in which the big particles are found.100 In this
regime, the relaxivity is a function of the echo time between two 180° pulses, hence the echo
time. If fiD > fiL the relaxation rate decrease with the radius101
R2 = 1:8fNP x
1=3(1:52 + fNP x)
5=3=fiD: (4.38)
For all three regions the phase shift ffi of a proton due to the presence of a magnetic particle
inducing a field B is
ffi = BIt (4.39)
where t is the the time of the proton in this field.104
From an MRI point of view, equation 4.38 is interesting, because of two points: First of all,
it is obvious that the relaxation rate decreases with the radius of the nanoparticle. Secondly,
the echo sequence plays an important role. If the echo times are too long, the refocusing
pulses are still inefficient like in the MA regime. But if the echo time tE is short enough,
it gets into the same region of the diffusion time fiD of the nanoparticles. That makes
refocusing pulses efficient and in the end the difference between T2 and T 2 .
The three different regimes are shown in in Figure 4.34. In the first regime there is no
difference between T2 and T 2 , refocusing pulses are inefficient because they are too long
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Figure 4.34: Relaxation rate R2 for increasing nanoparticle radii and different regions. In this example,
the MA regime is up to a size of around 10 nm. The region of the plateau is given by the
SD regime. In the EL regime, T 
2
is still constant (red line), whereas R2 is decreasing
(black line). The blue line is simulated for an echo time which is longer than in case of
the black line.
in comparison to the diffusion time. The plateau is described by the SD regime. Above a
certain size, in the EL regime, R2 start to decrease whereas R2 stays constant at the level of
the static dephasing regime. Additionally the relaxation rates for two different echo times are
shown. Like expected, the relaxation rate is increasing with longer echo times. The different
regimes are not as strictly separated as one might expect. Rather the different conditions
must be understood as approximations. This is also the reason why the curve has no smooth
transitions between different regimes.60
Having introduced the basic equations, the relaxivities can be simulated. All simulations
again have been performed with Matlab, the corresponding code can be found in section
8.3.3. First, with the help of Thermogravimetric Analysis (TGA) the number of SPIOs in a
nanoparticle and the number of nanoparticles in a given volume were calculated. The volume
occupied by inorganic content is denoted as %TGA, with which the average density of a
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particle calculated to be
 = SP IO %TGA + (100% %TGA)  Polymer (4.40)
with SP IO and Polymer being the weight density of a SPIO and the polymer of a NP,




   r3NP   (4.41)
in which rNP is the particle radius. The solid content per volume is obtained with solid






The iron oxide mass mFe3O4 can be calculated with m %TGA. The iron oxide core mass of




   r3SP IO  Fe3O4 (4.43)
where rSP IO is the iron oxide core radius and Fe3O4 the weight density of magnetite. The
radii of SPIOs has been analyzed via TEM images. In one nanoparticle one has ZSP IO SPIOs,





For SPIOs ZSP IO is one. In nanocapsules a big part is water, hence the approach to calculate








r3NC   (rNC   l)3
) (4.45)
where rNC denotes the hydrodynamic radius of the capsule and l the thickness of the capsule
wall. Based on TEM images, the capsule wall thickness is estimated to be 15 nm. The mass
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The number of SPIOs in one NC is calculated analogue to NPs. With ICP-OES the iron
concentration [Fe] is determined. Since the concentration is proportional to %TGA, the
number of particles in a volume of one liter and for a concentration of 1 mM can be calculated.
For the next step, the intra-aggregate volume ffiint needs to be introduced, which is the ratio
of the volume of iron oxide in a nanoparticle to the total volume of the nanoparticle.98,105
In this way the reduced iron content in a particle is considered, since big parts are polymer.
For the capsules, ffiint is calculated as ratio of the volume of iron to the volume of polymer
and iron, being equivalent to subtracting the water core from the capsule. Otherwise the
volume fraction fA would be overestimated. That in turn would lead to an overestimation of
the iron content and eventually to the overestimation of the relaxivity. The volume fraction
fA of particles or capsules is then given by
fA = Z 
4
3
  r3ex  ffiint ex 2 fSP IO;NP;NCg (4.47)
To calculate the magnetization M of the SPIO iron oxide core, the saturation mass magne-
tization is needed and can be determined with VSM.
M = ms  Fe3O4 (4.48)
where Fe3O4 is the density of magnetite. Because the SPIOs have a oleate coating on top,
the magnetic field felt by the water molecules is effectively reduced. That makes the SPIO
acting as a weakly magnetized sphere, which has then an effective radius of
r ef fSP IO = rSP IO + d (4.49)







(rSP IO + d)
3 (4.50)
where d is the thickness of oleate coating. To calculate the frequency shift !NP of clustered
magnetic nanoparticles, the magnetization of this cluster is needed, which is given by106
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The magnetization MNC of NCs and the frequency shift !NC is calculated in the same way.
After the fundamental parameters have been calculated and set in the Matlab code, the
relaxivities for the different systems are simulated with the equations introduced above. All
systems are redispersed in 1 wt% Agarose, for which the diffusion coefficient of water is
assumed to be the one in neat water. It has been found, that this is a very good approxima-
tion.43
4.2.3 The unified approach
Vuong et al. performed a Monte Carlo (MC) simulation on the classical theory and gained
an unified equation describing all three regimes with one equation.27 This approach has
one major advantage over the "classical" theory: It explicitly distinguishes for nanocapsules
between the "outer sphere" contribution, e.g. water that is relaxed by seeing the NC as
a weakly magnetized sphere and the "inner sphere" contribution, stemming from water
relaxed by the single SPIOs in the NC. The terms outer sphere and inner sphere must not be
confused with the one used like in the case of T1 contrast agents. In addition, this approach
allows water to diffuse into and out of the capsule. The simulation should therefore lead to
significantly better results in comparison to the classical theory, which is not considering the
inner sphere contribution. In one publication, SPIO loaded vesicles have been compared to
MC simulations.107 However, the authors were interested in the understanding of unexpected
relaxation rate behavior and not in developing a fundamental theory. Consequently, the
authors did not present any equations in the given reference. The equation describing all
three regimes is
runif2 (r; Beq; fA) = fA
(a  Beq  r)2
1 + b  r  Beq +
(








e  r  Beq
)4 (4.53)
in which r is the radius of the particle, Beq the equatorial field of the particle,  = 0.42, a =
2:5209  1012, b =  0:177  109, c = 0:1295  109, d = 0:0532  109, and e = 0:0566  109.27
For non-agglomerated systems like a single SPIO, the radius r is equal to the effective SPIO
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Hence, the relaxivity is given by




SP IO; Beq; fA) (4.55)
The relaxivity for NPs is calculated in the same manner by runif2 (rNP ; BNP ; fNP ) in which
rNP , BNP , and fNP stand for the hydrodynamic radius, the equatorial field, and the volume
fraction of the NP, respectively. The equatorial field is given by
BNP = ZSP IOBeq
(




For nanocapsules, one gets two contributions, one for the NCs acting as a weakly magnetized





The equatorial field BNC is calculated analog to equation 4.56 by replacing the NP radius
rNP with the NC radius rNC . Since the NC is carrying SPIOs, which itself can relax protons,
one has a second component for the volume fraction, which is the volume fraction of the
SPIOs inside the NC,
finner = ZSP IO 
(




where finner stands for the inner aggregate fraction and ffiint corresponds to ffiint of the
SPIOs. Now, one has two relaxation rates: One coming from the weakly magnetized NC,
and one coming from single SPIOs inside the NC. In the limiting case of very fast exchange
between bulk water and water inside the capsule, the relaxivity can be calculated with
rNC2 = pBulk  runif2 (rNC ; BNC ; fbulk) + pinner  runif2 (r ef fSP IO; Beq; finner ) (4.59)
where pbulk is the fraction of water molecules outside the capsule, and pinner the one inside
the capsules. Of course, the fraction outside the NC is nearly one, whereas pinner is very
small. For NCs the water exchange plays a crucial role, which is considered in the case of
the unified approach resulting in rMC2 . This exchange gives rise to a second contribution,
stemming from water coming in contact to single SPIOs, besides that coming from the NC
as a weakly magnetized sphere. The complete situation is sketched in Figure 4.35.
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Figure 4.35: Different NP morphologies (1,2) and how they are included in the simulation (4). NC
morphology (3) is included as it is. Blue spheres stand for water, orange spheres for iron
oxide particles, black dashed circles for the polymeric shell, green areas for polymeric
material.
4.2.4 Results and discussion
To differentiate the relaxivities simulated with the classical approach and the one gained with
the unified approach, they are called r class2 and r
MC
2 , respectively. The main parameters for
the different systems and outcome of the simulation is summarized in Table 4.5. The single
SPIOs are all in the MA regime. They have an increasing relaxivity with increasing diameter,
like expected. Only S-20 did not fit into the MA nor the SD regime, either the criterion




2! . However, as mentioned above, the different regimes are not as clearly separated
as one might expect from the given conditions.98,101 If S-20 is placed in the MA regime,
the simulation almost fits the experiment, if it is placed in the SD regime, the simulation
overestimates the experimental result by 200%. This is why S-20 is placed in the MA regime,
which is considered to describe SPIOs the best. For particles that are in the transition zone
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Table 4.5: Each column is: The system, the number of SPIOs per NP or NC, the measured r2, simu-
lated r2 by the classical approach and simulated r2 with the unified approach, respectively.
System ZSP IOs r2 [s 1mM 1] r class2 [s
 1mM 1] rMC2 [s
 1mM 1]
S-8 1 99  9 69 43
S-16 1 140  14 100 121
S-25 1 167  18 158 122
NP-146 468 216  12 94 76
NP-156 3959 165  5 253 281
NC-250 33 43  10 10 51
NC-400 959 114  4 13 19
VA-060-Low 24 55  3 13 89
VA-060-Med 39 120  11 13 89
VA-060-High 89 96  9 96 231
between two different regimes, polydispersity can lead to circumstances in which some parts
of the sample are in one regime, whereas the rest of the sample is actually in another
regime.98 The most interesting point for the SPIOs is probably the underestimation of the
measured values by a factor of two, in the case of the unified approach, resulting in a low
rMC2 . Deviations this high have already been reported in the original publication of Vuong et
al.27 There they investigated a system which is pretty close to S-8, namely SPIOs with radius
of 5 nm and a magnetization of 320 kA/m, for which they get an r ex2 of 100 s
 1mM 1and a
rMC2 of 50 s
 1mM 1. Both results fit well with the corresponding results gained here. Vuong
et al. attributed this deviation to the polydispersity of the samples. Generally speaking, the
polydispersity of samples in combination with size determination by TEM and DLS can lead
to big uncertainties.108,109 To see the dramatic influence on the relaxivity, the r2 for different
iron oxide sizes has been simulated. But this time a second simulation has been performed in
which the radius has a Gaussian noise of 25% of the radius, which correspond to the situation
of a 25% size deviation as observed for the different systems. That means, the values that
the radius can take on are in the area of r 0.25r . The result is shown in Figure 4.36. The
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Figure 4.36: Relaxivity r2 for different sizes of the iron oxide cluster. Black curve is simulated without
noise, blue curve is simulated with 25% gaussian noise on the radius.
outcome nonambiguously demonstrates, that the error on the radius can lead to a situation, in
which the simulated relaxivity is far off the experimental relaxivity. Moreover, to demonstrate
the effect of the coating, the magnetic field around a S-8 has been simulated with COMSOL
Multiphysics 4.3, see Figure 4.37. One can see, how the magnetic flux density around the
SPIO gradually decreases as one goes away from the surface. If one imagines a hydrophobic
coating on top, it is easy to see, that the magnetic field has already decreased to much
smaller values, even for a distance as low as 1 nm. In all theories, magnetic nanoparticles
are treated as weakly magnetized spheres, without taking into account the special conditions
that may arise by the use of different coatings.110 For example it is known, that a hydrophilic
coating on magnetic particles can drastically change the diffusion coefficient in the closer
environment of the cluster, which in turn impacts the relaxivity.111 Also, the size of the
coating around a SPIO is often just estimated, which leads to erroneous estimations of the
radii and again to wrong relaxivities. Especially in the case of small particles, the coating
can heavily influence the radius. Though there is still no exact procedure to account for the
coating, it is possible to consider polydispersity in the simulation.108 Unfortunately, because
of the already mentioned impact of the coating on the relaxivity, it is hardly possible to
compare different values found in literature. For example Jun et al. investigated a system
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Figure 4.37: Simulation of the magnetic flux density Bloc induced by a SPIO with 8 nm radius. The
black wiggly lines, bordered by the green dashed line, indicate a coating on top of the
iron oxide core. The green circle indicates the iron oxide core.
with a diameter of 9 nm and a magnetization of 80 emu/g, which is comparable to S-8. Still,
they found relaxivities which are 30% higher.112 To have a more general approach at hand,
a universal scaling law was developed, for which it was found that within good agreement




ffiint = 11:6  10 12
(
2r ef fSP IO
)2
(4.60)
where r ex2 stands for the experimentally determined relaxivity. The left side stands for the
experimentally determined values and the right side for the theoretically expected ones. If
there is a perfect matching between the measured and simulated values, both sides would
give the same result. Since all investigated SPIOs are in the MA regime, the scaling law can
be used to compare the experimental and theoretical values. The values found are 1:1  10 9
and 1:2  10 9 for the left and right side of equation 4.60, 1:8  10 9 and 3:8  10 9, and
4:2  10 9 and 5:9  10 9, for S-8, S-16, and S-20, respectively. These results agree well
with each other and the reported values in literature.98 Again, for this theoretical approach
systems have been found, which match poorly with the predicted values. Pothayee et al.
found for their system, with a hydrophilic coating, that the scaling law underestimates the
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experimental relaxivity by a factor of five.111
The next two systems are SPIO loaded nanoparticles. For both of them, the relaxivity is
higher than for the single SPIOs S-8, due to the effect of clustered SPIOs.106,109 The
simulations differ around 50% from the experimental results. Again it is very likely that the
radius plays the crucial role here.
The last systems are nanocapsules, which have relaxivities that are in the area of the one
for SPIOs and below the NPs. It is known, that vesicles like micellar and liposomic systems
can have relaxivities that are not much higher than the one of the single SPIOs they have
encapsulated.113,114 One can imagine that some loose aggregates form, but not permanent,
which prevents the NCs having relaxivities as high as these of NPs. Unfortunately, it is not
possible to gain any information on the SPIO distribution inside NCs. Clusters of SPIOs
seen on TEM images are probably drying artifacts. Since the SPIO distribution inside NCs is
highly dynamic, it is not possible to make any assumptions on the relaxation behavior. MC
simulations have shown, that linear aggregates formed out of SPIOs can have relaxivities
much smaller than the single SPIOs which are forming the linear aggregate.27 When the
relaxivities of the NCs are compared with r class2 and r
MC
2 , one notices that apart from one
case, r class2 heavily underestimates the relaxivity of nanocapsules. See also Figure 4.38,
where the simulated relaxivities are plotted against their experimental counterpart. Whereas
in the case of SPIOs and NPs there is only a slight deviation between the values from
r class2 and r
MC
2 , the values for NCs differ a lot from each other, depending on the chosen
simulation model. Since rMC2 is more detailed about the given conditions, the matching
between the simulated and the experimental values is improved. Though the deviations are
still big, the unified approach gives a more realistic impression, whereas the computed values
with the classical approach are off by a factor of 10 in comparison to r ex2 . The deviation
for both models might in parts be because of restricted diffusion inside the nanocapsules.
Like discussed in the previous section, for T1 contrast agents this is known to change the
outer sphere contribution.80 It has already been shown, that this can have an unconsidered
influence on the simulated relaxivity.111,115 Of course, erroneous results in size determination
are again a source of wrongly estimated relaxivities. However, considering the complexity of
the systems and the many assumptions made, it is already a success that the relaxivities can
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(blue) plotted against the experi-
mentally determined relaxivites r ex
2
. Crosses, filled circles, and hollow circles correspond
to SPIOs, NPs, and NCs, respectively. The black line indicates perfect matching. The
green dashed line borders the area of 50% deviation from r ex
2




be estimated in the right order of magnitude.
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The aim of this thesis was to investigate, understand and optimize nanocapsules as high
relaxivity contrast agents. Two kinds of contrast agents were investigated:
Firstly, positive contrast agents, for which the starting point were nanocapsules, exhibiting
relaxivities similar to that of commercially available contrast agents.18 To avoid a trial and
error approach, a very general concept of relaxivity was established by looking at the relaxivity
in different polymer solutions. In this work it was shown, that with only a few assumptions,
almost every relaxivity in solution could, at least qualitatively, be predicted by just taking the
viscosity into account. The influence of the temperature as well as of the magnetic field
strength was shown and simulations led to predictable results. Simulations also identified the
microviscosity, rather than macroviscosity as the determining parameter for the relaxivity.
The encapsulation of gadobutrol leads to high relaxivity values, up to a value of five times
the relaxivity of neat gadobutrol. In this work it was shown, that the water exchange is of
utmost importance for the relaxivity. By different techniques it has been shown, that the
proton exchange has an upper limit of some hundred s. Moreover, it was found out by
high field 17O and NMR dispersion measurements that the origin of the high relaxivity is the
restricted diffusion of water molecules in nanocapsules. The findings from the experiment
and the simulation for solution, led to the development of capsules which have sucrose co-
encapsulated and relaxivities which are increased ten times, in comparison to gadobutrol
alone. Finally, as demonstrated by in vitro and in vivo experiments nanocapsules can give
rise to a high local contrast in the MR image. In summary, in this work the source of high
relaxivity nanocapsules was investigated and understood and led to an increase in relaxivity
by a factor of ten and an increased contrast in in vivo imaging.
Secondly, nanocapsules have been investigated as T2 contrast agents. Three different
classes, SPIOs, nanoparticles and nanocapsules have been investigated using two different
approaches. One was the classical theoretical approach, the other one an unified approach
based on a MC simulation. It has been shown, that the relaxivities for different morphologies
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can be estimated with a semi-empirical approach, in which experimentally gained parameters
were used to predict the relaxivity. By that, the relaxivity for SPIOs as well as for nanopar-
ticles could be predicted qualitatively. It turned out, that the uncertainty in radius has a
large influence on the results. However, for nanocapsules the different approaches led to
very different results. In case of the classical theoretical approach, the unconsidered proton
exchange plays a crucial role and leads to heavily underestimated relaxivities in nearly all
cases. It was shown, that the unified approach, in which water or proton exchange is taken
into account, gives a better agreement between simulation and experiment. Again, like in the
case of T1 contrast agents, the proton exchange is a crucial factor in designing high relaxivity
nanocapsules. It has also been shown, that nanocapsules can have relaxivities similar to the
ones of clustered SPIOs in nanoparticles. The strength of nanocapsules is their combined
use as both contrast agent and drug carrier, which can release their cargo through thermal
decomposition and potentially other routes.33,116,117 Therefore, one must get more insight
into the relaxation rate behavior, for which the unified approach turned out to be a valuable
method. In summary, in this work the different parameters, which lead to high relaxivity T2
contrast agents have been determined in a semi-empirical approach and successfully used to
qualitatively predict the relaxivities.
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6 Zusammenfassung
Das Ziel dieser Arbeit war es, Nanokapseln als Hochrelaxivitätskontrastmittel zu untersuchen,
zu verstehen und zu optimieren. Es wurden zwei Arten von Kontrastmitteln untersucht:
Erstens wurden sogenannte positive Kontrastmittel untersucht, für welche der Ausgangspunkt
Nanokapseln waren, mit Relaxivitäten ähnlich denen von bereits kommerziell erhältlichen Kon-
trastmitteln.18 Um ein rein systematisches Ausprobieren zu vermeiden, wurde die Relaxivität
zunächst ganz allgemein untersucht in verschiedenen Polymerlösungen. In dieser Arbeit kon-
nte gezeigt werden, dass mit nur wenigen Annahmen, beinahe jede Polymerlösung und deren
Relaxivität zumindest qualitativ gut beschrieben werden kann, indem lediglich die Viskosität
als Parameter mitberücksichtigt wurde. Der Einfluss der Temperatur und des Magnetfeldes
auf die Relaxivität wurde untersucht und konnte über Simulationen auch beschrieben werden.
Desweiteren konnte über Simulationen gezeigt werden, dass die Mikroviskostität und nicht die
Makroviskosität entscheidend ist für die Relaxivität. Die Verkapselung von Gadobutrol führt
zu Relaxivitäten, welche bis zu sechs mal größer sind als die von reinem Gadovist. Es hat sich
herausgestellt, dass der Protonenaustausch von höchster Wichtigkeit ist, damit Nanokapseln
als Kontrastmittel funktionieren können. Über verschiedene Techniken wurde demonstri-
ert, dass der Protonenaustausch schneller sein muss als ein paar hundert Mikrosekunden.
Desweiteren haben 17O und NMR Dispersion Messungen gezeigt, dass die Kapselwände zu
einer Veränderung der Diffusion und damit zu einer erhöhten Relaxivität führen. Die Erken-
ntnisse, gefunden über Experimente und Simulationen in verschiedenen Polymerlösungen,
führten zur Entwicklung von Kapseln, in welchen zusätzlich Zucker verkapselt ist. Dies
wiederum führte dazu, dass die Relaxivität nochmal auf einen Faktor zehn gegenüber ein-
fachem Gadovist gesteigert werden konnte. Zusammenfassend kann gesagt werden, dass in
dieser Arbeit Nanokapseln untersucht und das Zustandekommen der hohen Relaxivität identi-
fiziert und verstanden wurde. Dies führte zur Entwicklung von Kapseln mit einer Relaxivität,




Zweitens wurden Nanokapseln als negative Kontrastmittel untersucht. Drei verschiedene
Arten wurden untersucht, nämlich superparamagnetische Eisenoxide, Nanopartikel in welchen
superparamagnetische Eisenoxide einpolymerisiert wurden und Nanokapseln, in welchen su-
perparamagnetische Eisenoxide verkapselt waren. Für die Simulation der Systeme wur-
den zwei Ansätze gewählt: Zum einen der klassische Ansatz über die sogenannte outer
sphere Theorie und ein zweiter, sogenannter vereinheitlichter Ansatz, basierend auf MC-
Simulationen. Die Relaxivitäten für die verschiedenen Arten von Kontrastmitteln und ver-
schiedenen Morphologien konnten über einen semi-empirischen Ansatz abgeschätzt werden, in
welchem experimentell erhaltene Daten genutzt wurden, um die Relaxivitäten vorherzusagen.
Es hat sich herausgestellt, dass die Polydispersität einen großen Fehler in den Rechnun-
gen verursacht, trotzdem konnte die Relaxivität von superparamagnetischen Eisenoxiden und
auch von Nanopartikeln qualitativ bestimmt werden. Für Nanokapseln hingegen führten die
zwei gewählten theoretischen Ansätze zu fundamental verschiedenen Ergebnissen. Mit den
klassischen theoretischen Ansätzen führte der nicht berücksichtigte Wasser- bzw. Protone-
naustausch zu stark unterschätzten Relaxivitäten. Der vereinheitlichte Ansatz hingegen, in
welchem der Austausch von Protonen mit berücksichtigt wird, ergab eine Verbesserung in der
Übereinstimmung zwischen Experiment und Simulation. Wie im Falle der T1 Kontrastmittel
spielt der Protonenaustausch eine entscheidende Rolle für die Relaxivität von Nanokapseln.
Desweiteren haben die Messungen ergeben, dass Nanokapseln Relaxivitäten haben können,
welche mit denen von einfachen Eisenoxidpartikeln konkurrieren können. Der Vorteil der
Nanokapseln liegt in der simultanen Nutzung als Kontrastmittel und Wirkstoffträger.33,116,117
Daher ist es nötig, weitere Einsichten in das Relaxationsverhalten zu bekommen, für welche
der vereinheitlichte Ansatz eine wertvolle Methode sein kann. Zusammenfassend konnte in
dieser Arbeit gezeigt werden, dass über einen semi-empirischen Ansatz die Relaxivitäten von
T2-Kontrastmitteln, speziell auch Nanokapseln, qualitativ berechnet und vorhergesagt werden
können.
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7.1 Positive contrast agents
7.1.1 Relaxivity in solution - Simulation
To compare the experimentally gained relaxivities with theoretical expectations, a semi empir-
ical simulation based on SBM theory have been performed. For the outer sphere contribution
the Hwang Freed model was used.
First, the parameters are taken from literature and set at the beginning. Please note, that
the parameters are named according to according Matlab file 8.3.2, namely
S = 7/2 the electronic spin of Gd(III)9
r = 3.110 10 the distance in the inner sphere of gadolinium to water71
pm = 10 3/55.56 the mMol fraction of Metal ions per solvent molecule for 1 mM of gadolin-
ium17
A = 2.8106 hyperfine coupling constant71
d = 0.3610 9 distance of closest approach for outer sphere contribution71
d0 = 9  10  10 estimated diameter of gadobutrol. Platzek et al. found that the volume V of
the gadobutrol complex is 2200 Å3.118 The diameter is approximated under the assumption,





dH2O = 310 10 diameter of H2O molecule119
dsuc = 9.410 10 diameter sucrose120
S = 37.2 entropy of the activation process of the water exchange between inner sphere and
bulk phase71




2:4 mean-square of the zero field splitting energy
71
tv298 = 6.510 12 correlation time which modulates the electronic relaxation of the gadolin-
ium71
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Table 7.1: Viscosities for different sucrose concentrations and temperatures. The subscript at 
indicates the wt% of sucrose in solution.
T [K] 0 [mPas] 15 [mPas] 30 [mPas] 40 [mPas] 50 [mPas] 65 [mPas]
278 1.5 3.2 5.5 11.5 33.4 484.1
283 1.3 2.7 4.5 9.2 25.4 315.3
288 1.2 2.3 3.8 7.5 19.7 212.8
293 1.0 2.0. 3.0 6.2 15.5 148.0
298 0.9 1.7 2.8 5.2 12.5 106.1
303 0.7 1.5 2.4 4.4 10.2 77.9
308 0.5 1.3 2.1 3.8 8.4 58.4
313 0.3 1.2 1.8 3.3 7.0 44.7
E = 0.9 the activation energy for tv29871
After the parameters have been set, one can simulate the relaxivity, with the equations given
in section 4.1.1.
In order to describe the relaxivity as a function of viscosity, the viscosities for different tem-
peratures and sucrose concentrations are set. The values can again be found in literature.121
They are summarized in Table 7.1.
Then the diffusion coefficient, for different temperatures T and different sucrose concentra-





i 2 fH2O; suc; gdg (7.1)
where di is the diameter of the water (H2O), the sucrose (suc), or the gadobutrol (gd)
molecule, respectively. Then the spectral density functions are calculated. Since the sucrose
molecules themselves are bearing protons, they contribute to the 1H signal. Hence, they need
to be considered in the simulations, but only in the outer sphere contribution to relaxivity,
because the sucrose molecule is too big to enter the first coordination sphere of the gadolin-
ium complex, like it is known for Mn2+ nitrate.75 Though one could argue, that for higher
82
7 Experimental and Simulations
sucrose concentrations the total amount of water decreases, which would affect the inner
sphere contribution, one has to consider, that due to proton exchange of the -OH groups of
sucrose and water, there is always water which can enter the inner sphere of the gadobutrol
complex. It has also been shown, that the water exchange between the inner sphere and
the bulk phase is unaffected by changes outside at the inner coordination sphere.74,122 For
the outer sphere contribution, one has to consider, that the sucrose molecules are diffusing
slower than the water molecule, because of their size. Therefore, the amount of protons pro-
vided by water and by sucrose molecules have been calculated. First, the amount of protons
stemming from water nH2O in solution has been calculated, with




where wt% is the weight percentage for the corresponding sucrose solution and the 2 is
coming from the two protons of a water molecule. The 55.55 mol is the molarity of 1 l of
water. Then, based on the wt% of sucrose, the number of protons coming from sucrose
nsuc is calculated with
nsuc = 22  wt%  1000
Msuc
(7.3)
whereMsuc = 342 g/mol is the molecular weight of sucrose and the 22 the number of protons
coming from one sucrose molecule. Eventually, the fraction of protons actually coming from





Then one can calculate two outer sphere contributions, one coming from the protons of the
water molecules
ROS1;H2O = c  f (fiDH2O) (7.5)
where f stands for the function describing the outer sphere term and fiDH2O the diffusional
correlation time of water. And the second contribution stems from the sucrose
ROS1;suc = (1  c)  f (fiDsuc ) (7.6)
with fiDsuc denoting the diffusional correlation time of sucrose.
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7.1.2 Relaxivity for different diffusion coefficients
To test ternary solutions other than gadobutrol, water and sucrose, the sucrose was replaced
by different polymers. To calculate the relaxivity not based on the macroscopic viscosity
but on the diffusion coefficients, again simulations based on the SBM theory with the OS
described by the Hwang Freed model were performed. The code is shown in section 8.3.2.
First, the diffusion coefficients of water found for several solutions are set in the beginning. In
many cases, not the exact same conditions could be found but instead the diffusion coefficient
for the system closest to the investigated one is used. The diffusion coefficients are listed
in Table 7.2. For sucrose, water diffusion coefficients for 303 K, 323 K and 343 K are
available. However, with a line fit it was found that the diffusion coefficient in this region
behaves almost linearly. Therefore, the average of the diffusion coefficient for 303 K and 323
K was calculated. The same is true for Trehalose. For Dextran, different molecular weights,
hence chain lengths were used, like 6k, 40k and 70k. However, the chain length showed no
impact on the relaxivity, only the wt% made the difference and in fact, 10 wt% of 35k Dex
and 10 wt% of 70k Dex give the same relaxivity. Therefore, the water diffusion coefficient
found in a solution together with 70k Dex was used. The same is true for the PEG systems,
again different chain lengths did not result in any difference in the relaxivities. For the PEG
systems, only diffusion coefficients for 278 K and 333 K were found. However, the difference
between the two temperatures was only about 10%.126 Therefore, again the average of
the diffusion coefficient found for 278 K and 333 K was calculated. For PVA two different
degree of hydrolysis were used. But it was found that the water diffusion coefficient is not
dependent on the degree of hydrolysis.127 For all systems, the diffusion of the polymer was
not considered. That is because only the relative diffusion of the gadobutrol complex and the
polymer was considered, which is dominated by the much faster diffusion of the gadobutrol
complex.





where rH2O is the radius of a water molecule and DL the diffusion coefficient of water like
found in literature. With micro all other parameter depending on the viscosity are calculated,
like the diffusion coefficient of the gadobutrol complex, the rotational correlation time and so
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Table 7.2: Diffusion coefficients of water for different solutions. P : Polymer in solution; wt%: weight
percentage of polymer; PL: Polymer found in literature; wt%: Weight percentage found
in literature; D: Diffusion coefficient found in literature.a.): Diffusion coefficient is the
average of 303 K and 323 K. b.): The temperature was 298 K. c.): Diffusion coefficient
is average of 278 K and 333 K. d.): Water diffusion is not depending on the degree of
hydrolysis. For all: Please see details in the text.
P wt% PL wt%L D  109 [m2/s]
H2O123 100 H2O 100 2.9
Sucrose124 15 Sucrosea) 16 2.0
Sucrose124 30 Sucrosea) 32 1.3
Sucrose124 40 Sucrosea) 43 0.9
Sucrose124 50 Sucrosea) 55 0.5
Sucrose124 65 Sucrosea) 66 0.2
Trehalose124 10 Sucrosea) 16 1.9
Trehalose124 30 Sucrosea) 32 1.1
6k Dex125 3 70k Dexb) 3 1.6
40k Dex125 10 70k Dexb) 10 1.6
40k Dex125 20 70k Dexb) 25 1.2
40k Dex125 30 70k Dexb) 33 0.7
70K Dex125 5 70k Dex 3 1.7
70K Dex125 10 70k Dex 10 1.6
70k Dex125 35 70k Dex 33 0.6
0.4k PEG126 10 0.4k PEGc) 10 1.6
8k PEG126 10 20k PEGc) 10 1.6
35k PEG126 2 20k PEGc) 2 2.1
35k PEG126 6 20k PEGc) 6 1.6
35k Peg126 10 20k PEGc) 10 1.6
35k PEG126 20 20k PEGc) 20 1.2
35k PEG126 30 20k PEGc) 30 0.9
PVA 80%127 10 PVAd) 10 2.0
PVA 90%127 10 PVAd) 10 2.0
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on. The rest is calculated as described above, again considering the outer sphere contribution
separately for the polymer and the water.
7.1.3 Relaxivity for unloaded nanocapsules
To obtain a relaxivity for nanocapsules that actually have no gadobutrol encapsulated, the
number of capsules in solution has been estimated based on the solid content. The sample
has been freeze dried and the total weight of all nanocapsules mtot measured. With an







r3   (r   d)3) (7.8)
where d is the thickness of the polymer shell and r the radius of the capsule. With that, the
mass of one capsule mnc can be calculated via
mnc = p  Vps (7.9)





It has been found, that the number of capsules has around the same order of magnitude
in case of capsules with and without gadobutrol inside. Hence, one can correlate unloaded
nanocapsules to a certain gadolinium concentration.
7.1.4 In vivo experiments
For analyzing the in-vivo experiments ImageJ 1.48v has been used, a picture analyzing tool
free of charge. With that, a region of interest (ROI) on an image is drawn and after that the
intensity analyzed. Then, for different times, the intensity for a certain ROI can be analyzed
and plotted against the time. By that, the change in signal intensity over time is analyzed.
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In the first two sections, the most important abbreviations and parameters are summarized.
Then, the most important Matlab codes are shown.
8.1 Abbreviations
ARTDECO Altered Relaxation Times Detect Exchange Correlation
(NMR sequence for measuring Water exchange)
CA Contrast Agent
CGS Centimetre Gram Second (Metric system)
CPMG Carr, Purcell, Meiboom, and Gill (NMR pulse sequence)
DAB 1,4-diamino butane
DAB-NC Nanocapsules made from DAB in a ratio 1:1.5 to TDI,
with 10 mM gadobutrol
DAE 1,2-diamino ethylene
DAE-NC Nanocapsules made from DAE in a ratio 1:1.5 to TDI,
with 10 mM gadobutrol
DAH 1,6-diamino hexane
DAH-NC Nanocapsules made from DAH in a ratio 1:1.5 to TDI,
with 10 mM gadobutrol
FDA U.S. Food and Drug Adminstration
FID Free Induction Decay (Signal in NMR)
MC Monte Carlo
MRI Magnetic Resonance Imaging
NC Nanocapsule
NMR Nuclear Magnetic Resonance




SBM Solomon, Bloembergen, and Morgan (Relaxation theory)
SE Spin Echo (MRI pulse sequence)
SPIO Superparamagnetic Iron Oxide
TDI 2,4-toluene diisocyanate
8.2 Parameters
B0 Static external magnetic field [T]
! Difference in Larmor frequency between bulk and particle surface [Hz]
[c ] Concentration of contrast agents [mmol/L]
 Viscosity [mPas]
I Nuclear gyromagnetic ratio [Hz/T]
kB Boltzmann constant [J/K]
0 Permeability of vacuum [Vs/Am]
B Bohr magneton [J/T]
sp Magnetic moment of one elementary iron oxide crystal [J/T]
NA Avogadro constant
ri Relaxivity with i 2 f1; 2g [s 1mM 1]
Ri Relaxation rate with i 2 f1; 2g [s 1]
Rdiai Diamagnetic relaxation rate with i 2 f1; 2g [s 1]
T Absolute temperature [K]
fic Correlation time [s]
fiD Diffusional correlation time [s]
tE Echo time [s]
Ti Relaxation time with i 2 f1; 2g [s]
fim Residence time of water molecule at metal ion [s]
fir Rotational correlation time [s]




Here the most important home written matlab codes which have been used are shown.
8.3.1 Automatic evaluation of relaxation times
This home written Matlab code has been used to automatically read in and evaluate T1 and
T2 relaxation time measurements:
1 %% Automated evaluation of T1 and T2
2 %*******************************************
3 %* Sandro Ebert, 10/2012
4 %*******************************************
5 %%
6 clc; clear all; close all;
7 %+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
8 pathname_pro = 'C:\Work\MRI\T1 und T2 Messungen\Kerstin\001\001\';
9
10 T2_est = 100*10^3; %expected value for T2
11 %% Calculation





17 file_name = 'tau.dat';
18 tau = dlmread(file_name);
19 npts = length(tau);
20
21 A=zeros(size(tau));
22 %% Reading parameters
23 for n=1:npts;
24 cd(dir_name)
25 file_name = ['EXP',num2str(n),'.00001.Par.Txt'];
26 fid = fopen( file_name,'r'); % open file mit Name fname
27 fseek(fid,0,'bof'); % Sets pointer at beginning of file
28 string = char(fread(fid,inf,'char')');
29
30 s = strfind(string,'NECH'); %number of echos
31 if isempty(s)==0;
32 fseek(fid,s + 13,'bof');
33 NECH = str2double(char(fread(fid,4,'char')'));





37 s = strfind(string,'SI'); % SI
38 if isempty(s)==0;
39 for k = 1:2; % splits the resulting two pointer values
40 eval('s(k);'); % because SI matches different parameters
41 end
42 fseek(fid,s(1) + 12,'bof'); % matching for 'SI', not the others
43 SI = str2double(char(fread(fid,4,'char')'));




48 data_name = 'T2.Dat';
49 c=dlmread(data_name);
50 s2(:,1)=c(:,n); s4 = zeros(SI,NECH); T = zeros(NECH,1);
51 laufindex = zeros(SI,1);
52
53 for i= 1:NECH % Integrating the echos
54 T(i,1) = 2*tau(n)*i;
55 for j = (i 1)*SI + 1: (i 1)*SI + SI;
56 l = j (i 1)*SI;





62 if SI == 1 %In case of only one point, sum(s4) is wrong
63 s3 = s4';
64 else
65 s3(:,1) = sum(s4);
66 end
67
68 T = dlmread('EXP1.00001.Dat.Txt');
















83 A(n,2)=fit(2); % T2 time
84 A(n,3)=sqrt(COVB(2,2)); % standard error (Like in Origin 8.5)
85 end
86
87 % R2 for the single echos
88 R2=1./(A(:,2)/10^6);
89 error_R2 = (1./(A(:,2)./10^6).^2).*A(:,3)./10^6;
90
91 %%%%%%%%%%%%%%%%%%% Evaluation of T1 %%%%%%%%%%%%%%%%
92 dir_name=[pathname_pro 'T1\'];
93 fname = [dir_name 'T1_invrec.dat'];
94 c=dlmread(fname);
95 [C,I] = min(c(:,3));
96
97 s=zeros(3,1);
98 exp_T1='s(1)*abs(1 2*exp( c(:,1)/s(2))) + s(3)'; % For Inv Rec Fit
99 f=inline(exp_T1,'s','c(:,1)');
100
101 ev_T1 = [ max(c(:,3)), c(length(c),1)/5, max(c(:,3))];
102
103 [fit_a,r,J,COVB,mse]=nlinfit(c(:,1),c(:,3),f, ev_T1);










114 fprintf(['T_2 [ms] = ',num2str(fit(2)/10^3,'%1.2f'), '\n']);
115 fprintf(['R_2 (averaged) [Hz] = ',num2str(R2_av,'%1.2f')...
116 , ' +/  ' num2str( error_R2_av,'%1.2f') '\n\n']);
117
118 fprintf(['T_1 [ms] = ',num2str(T1,'%1.2f')...
119 , ' +/  ' num2str(Delta_T1,'%1.2f') '\n']);
120 fprintf(['R_1 [Hz] = ',num2str(R1,'%1.2f')...






125 plot(c(:,1)/10^6, c(:,3)), hold on; plot(c(:,1)/10^6,z_T1), hold off
126 title('T_1'); xlabel('Delay [s]'); ylabel('Signal intensity [a.u.]')
127 set(gcf, 'Color', 'w'); axis tight;
128
129 subplot(2,1,2)
130 plot(T, s3(:,1)); hold on; axis tight;
131 plot(T,y, 'r'), hold off; set(gcf, 'Color', 'w');
132
133 status = fclose( 'all'); % closes all open files
8.3.2 Relaxivity in solution for different viscosities
To calculate relaxivites for different solutions with Gadovist , based on diffusion coefficients,
the following code has been used:
1 %% Calculation of relaxivity based on diffusion constants
2 %*******************************************
3 %* Sandro Ebert, 2014
4 %*******************************************
5 clc; close all; clear all;
6 %% Measured data
7 r1 = [2.8 4.1 8.7]'; % Measured relaxivity
8 etha = [1 4.1 8.7]*10^ 3; % Macroviscosity
9 percprot = [1 0.83 0.66]'; % Percentage of molecule protons
10 percIS = [1 1 1]; % IS percentage
11 D = [2.9 2 1.3]'*10^ 9; % Experimental diffusion constant of H2O
12 D_mol = [0 20.6 18.2]'*10^ 11; % Exp. diffusion constant of molecule
13 d_mol = [0 9.4 9.4]'*10^ 10; % diameter molecule
14 %% Constants
15 S = 7/2; % spin
16 gamma_I = 2.675*10^8; % gyromagnetic ratio
17 mu_0 = 4*pi*10^ 7; % permeability of vacuum
18 g = 2;
19 mu_B = 9.274*10^ 24; % Bohr magneton
20 p_m = 10^ 3/55.56; % mMol fraction of Metal ions
21 N_A = 6.02*10^23;
22 A = 2.8*10^6; % hyperfine coupling constant
23 r = 3.1*10^ 10; % proton metal ion distance
24 d = 0.36*10^ 9; % distance of closest approach (OS)
25 d_0 = 9*10^ 10; % Diameter of Gadobutrol
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26 d_mole = 3.6*10^ 10; % dist. of closest approach molecule
27 d_H2O = 3*10^ 10; % Diameter of H2O particle
28 k_B = 1.38*10^ 23;
29 R = 8.314;
30 Delta_S = 37.2; % Entropy of the process
31 Delta_H = 47.4*1000; % Enthalpy of the process
32 h = 6.62*10^( 34); % Planck constant
33 Delta = 1.56*10^20/2.4; % ZFS Tensor
34 t_v298 = 6.5*10^ 12;
35 Delta_E = 0.9*1000;
36 B_0 = 1.5; % Main field [T]
37 T = 310; % Temperature in K
38 %% zero functions
39 j=zeros(length(r1)); j2=zeros(length(r1)); R1_OS=zeros(1,length(r1));
40 R1=zeros(length(r1),4); a=zeros(length(r1),2); R1_S = zeros(length(r1));
41 j_mol =zeros(length(r1),1); j2_mol =zeros(length(r1),1);
42 a_mol =zeros(length(r1),2);
43 %% Calculation
44 omega = gamma_I*B_0; omega_s=657.4*omega;
45 C1 = 2/15 * (mu_0/(4*pi))^2 * gamma_I^2*g^2*mu_B^2*S*(S+1)/r^6;
46
47 etha2 = k_B*T./(6*pi.*D*d_H2O/2);
48 etha2(25) = k_B*T./(6*pi.*D_mol(25).*d_mol(25)/2);
49
50 t_v = t_v298*exp(Delta_E/R*(1/T   1/298.15));
51 B = 1/ 25 * Delta * t_v *(4*S*(S+1)  3) * ...
52 ( 1/(1+omega_s^2*t_v^2) + 4/(1 + 4*omega_s^2*t_v^2));
53 C = 1/ 50 * Delta * t_v * (4*S*(S+1)  3)*...
54 (3 + 5/(1+omega_s^2*t_v^2) + 2/(1 + 4*omega_s^2*t_v^2));
55 T_e = 1/B; T_e2 = 1/C;
56
57 t_m = h/(k_B*T*exp(Delta_S/R   Delta_H/(R*T)));
58
59 for i=1:length(D_mol)
60 if D_mol(i) == 0




65 D_Gado = k_B*T./(6*pi.*etha2*d_0/2); %Diffusion Gadobutrol
66
67 D_mol = D_Gado + D_mol;




70 t_D = d^2./D; t_D_mol = d_mole^2./D_mol;
71 t_r = 4*pi*(d_0/2)^3.*etha2/(3*k_B*T);
72
73 z = 1/t_m + 1./t_r + 1/T_e; b = 1/t_m + 1./t_r + 1/T_e2;
74 t_c = 1./z; t_c2 = 1./b;
75 tau_e2 = 1/t_m + 1/T_e2;
76
77 for l = 1:length(r1);
78
79 a(l,1) = sqrt(1i*omega*t_D(l) + t_D(l)/T_e );
80 a(l,2) = sqrt(1i*omega_s*t_D(l) + t_D(l)/T_e2 );
81 a_mol(l,1) = sqrt(1i*omega*t_D_mol(l) + t_D_mol(l)/T_e );
82 a_mol(l,2) = sqrt(1i*omega_s*t_D_mol(l) + t_D_mol(l)/T_e2 );
83
84 j(l) = (4 + a(l,1) ) / ( 4 + 4*a(l,1) ...
85 + 21/9*a(l,1)^2 + 4/9*a(l,1)^3 );
86 j2(l) = (4 + a(l,2) ) / ( 4 + 4*a(l,2) ...
87 + 21/9*a(l,2)^2 + 4/9*a(l,2)^3 );
88
89 j_mol(l) = (4 + a_mol(l,1) ) / ...
90 ( 4 + 4*a_mol(l,1) + 21/9*a_mol(l,1)^2 + 4/9*a_mol(l,1)^3 ) ;
91 j2_mol(l) = (4 + a_mol(l,2) ) / ...
92 ( 4 + 4*a_mol(l,2) + 21/9*a_mol(l,2)^2 + 4/9*a_mol(l,2)^3 ) ;
93
94 R1_OS(l) = percprot(l)*32*pi/405* C1*15/2 * r^6 * N_A *...
95 real( 3 * j(l) + 7 * j2(l) ) / (d*D(l)) + ...
96 (1 percprot(l))*32*pi/405* C1*15/2 * r^6 *...
97 N_A * real( 3 * j_mol(l) + 7 * j2_mol(l) ) /...
98 (d_mole*D_mol(l));
99
100 R1_S(l) = 2/3*S*(S + 1)*A^2*( tau_e2^ 1 /...
101 ( 1 + omega_s^2 * t_c2(l)^2 ) ); % Scalar contribution
102 R1(l,1) = C1 *( 3*t_c(l)/(1 + omega^2*t_c(l)^2 ) +...
103 7*t_c2(l)/(1 + omega_s^2 * t_c2(l)^2)); % dipolar contribution
104
105 R1(l,2) = p_m / ( 1/(R1(l,1) + R1_S(l)) + t_m) + R1_OS(l); % r1
106 end
107
108 D_calc = k_B*T./(6*pi.*etha*d_H2O/2) + k_B*T./(6*pi.*etha*d_0/2);
109
110 %% Calculation with Macroviscosity
111 R1_MV=zeros(length(r1),4);
112





116 D_mol(i) = k_B*T/(6*pi*etha(i)*d_mol(i)/2); %Diffusion molecule
117 end
118
119 D_Gado = k_B*T./(6*pi.*etha*d_0/2); %Diffusion Gadobutrol
120
121 D_mol = D_Gado' + D_mol;
122 D_MV = D_Gado + D_MV;
123
124 t_D = d^2./D_MV;
125 t_D_mol = d_mole^2./D_mol;
126 t_r = 4*pi*(d_0/2)^3.*etha/(3*k_B*T);
127
128 z = 1/t_m + 1./t_r + 1/T_e; b = 1/t_m + 1./t_r + 1/T_e2;
129 t_c = 1./z; t_c2 = 1./b;
130 tau_e2 = 1/t_m + 1/T_e2;
131
132 for l = 1:length(r1);
133
134 a(l,1) = sqrt(1i*omega*t_D(l) + t_D(l)/T_e );
135 a(l,2) = sqrt(1i*omega_s*t_D(l) + t_D(l)/T_e2 );
136 a_mol(l,1) = sqrt(1i*omega*t_D_mol(l) + t_D_mol(l)/T_e );
137 a_mol(l,2) = sqrt(1i*omega_s*t_D_mol(l) + t_D_mol(l)/T_e2 );
138
139 j(l) = (4 + a(l,1) ) / ...
140 ( 4 + 4*a(l,1) + 21/9*a(l,1)^2 + 4/9*a(l,1)^3 );
141 j2(l) = (4 + a(l,2) ) / ...
142 ( 4 + 4*a(l,2) + 21/9*a(l,2)^2 + 4/9*a(l,2)^3 );
143
144 j_mol(l) = (4 + a_mol(l,1) ) / ...
145 ( 4 + 4*a_mol(l,1) + 21/9*a_mol(l,1)^2 + 4/9*a_mol(l,1)^3 ) ;
146 j2_mol(l) = (4 + a_mol(l,2) ) / ...
147 ( 4 + 4*a_mol(l,2) + 21/9*a_mol(l,2)^2 + 4/9*a_mol(l,2)^3 ) ;
148
149 R1_OS(l) = percprot(l)*32*pi/405* C1*15/2 * r^6 * N_A *...
150 real( 3 * j(l) + 7 * j2(l) ) / (d*D(l)) + ...
151 (1 percprot(l))*32*pi/405* C1*15/2 * r^6 * N_A * ...
152 real( 3 * j_mol(l) + 7 * j2_mol(l) ) / ...
153 (d_mole*D_mol(l));
154
155 R1_S(l) = 2/3*S*(S + 1)*A^2*( tau_e2^ 1 / ...
156 ( 1 + omega_s^2 * t_c2(l)^2 ) ); % Scalar contribution
157 R1(l,1) = C1 *( 3*t_c(l)/(1 + omega^2*t_c(l)^2 ) + ...
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158 7*t_c2(l)/(1 + omega_s^2 * t_c2(l)^2)); % dipolar contribution
159
160 R1_MV(l,2) = p_m / ( 1/(R1(l,1) + R1_S(l)) + t_m) + R1_OS(l);% r1
161 end
162
163 r1a = R1(:,2);
164 r1_MV = R1_MV(:,2);
165
166 quot = (r1a r1)./r1*100;
167
168 dev = round(sum(abs(r1a r1))/(length(r1a))*10)/10;






175 y=linspace(1,l,l); line = zeros(l,1); linegreen = 50*ones(l,1);
176 linegreen2 = 25*ones(l,1);
177
178 figure(3)
179 loglog(etha(1,1:l), D(1:l,1)); hold on; loglog(etha,D_calc); hold off;
180 legend({'Measured', 'Calculated'})
181 xlabel('Viscosity [mPas]'); ylabel('Diffusion constant [m^2/s]');
182
183 r1sort = r1; r1asort=r1a; r1_MVsort=r1_MV;
184 [etha,I] = sort(etha,2);
185 for i=1:length(I)
186 r1sort(i) = r1(I(i));
187 r1asort(i) = r1a(I(i));




192 semilogx(etha,r1sort); hold on; semilogx(etha,r1_MVsort); hold on;
193 semilogx(etha,r1asort); hold off;
194 xlabel('Viscosity [mPas]'); ylabel('Relaxivity [Hz/mM]'); axis tight;
195
196 figure(5)
197 semilogx(etha2*1000,r1); hold on; semilogx(etha2*1000,r1a); hold off;
198 title('\color{blue}SIM \color{black}vs. EXP')
199 xlabel('Calc. microviscosity [mPas]'); ylabel('Relaxivity [Hz/mM]');
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8.3.3 Negative contrast agents - Matlab code
The code to calculate relaxivites for agglomorated SPIO systems and the theoretical relax-
ivity:
1 %% Calculation of relaxivity for agglomorated iron oxides
2 %*******************************************
3 %* Sandro Ebert, 2014
4 %*******************************************
5 clc; close all; clear all;
6
7 mu_0 = 4*pi*10^ 7; % permeability of vacuum
8 gamma_I = 2.675*10^8; % gyromagnetic ratio
9 % Measured r2:
10 R2_mess = [99, 140, 167, 216, 165, 49, 120, 114, 96, 55];
11 % Radius of NP:
12 a_exp = [4.23, 8.05, 10.25, 73, 78, 125, 100, 200, 100, 100]*10^ 9;
13 % Number of SPIOS/NP:
14 N_exp = [1, 1, 1, 468, 3959, 33, 39, 959, 89, 24];
15 % concentration for 1 cubicmeter
16 C_exp = [6830, 656, 368, 12.7, 1.2, 4.4, 11.2, 2, 9.9, 18.6]*10^16;
17 % Magnetization of SPIOS:
18 m = [80, 62, 45, 80, 80, 45, 62, 80, 62, 62];
19 r_sp = [4.23, 8.05, 10.25, 4.23, 4.23, ...
20 10.25, 8.05, 4.23, 8.05, 8.05]*10^ 9;
21 % Density magnetite:
22 rho = [5.1, 5.368, 5.1, 5.1, 5.1, 5.1, 5.368, 5.1, 5.368, 5.368]*10^3;
23 % Half of echo time:
24 TE = [110, 110, 110, 110, 110, 110, 110, 110, 110, 110]*10^ 6;
25 D = [1.8, 2.9, 1.8, 1.8, 1.8, 1.8, 2.9, 1.8, 2.9, 2.9]*10^ 9;
26 % To calculate with radius of NP:
27 s = [1, 1, 1, 0, 0, 2, 2, 2, 2, 2];
28 q = [1, 1, 1, 0, 0, 2, 2, 2, 2, 2];
29 d_SPIO = 1*10^ 9; % length coating
30 f_A = N_exp.*C_exp.*4/3*pi.*r_sp.^3; % volume fraction
31 % Percentage of iron oxide in particle
32 corr = [0.53, 0.71, 0.76, 0.09, 0.64, 0.05, 0.03, 0.04, 0.11, 0.03];
33
34 r_np = zeros(size(s)); delta_omega = zeros(size(s));
35
36 for i = 1:length(s)
37




40 r_np(i) = r_sp(i)+d_SPIO;
41 f_A(i) = f_A(i)*r_np(i)^3/r_sp(i)^3*corr(i);
42 delta_omega(i) = mu_0*gamma_I*m(i)*rho(i)*r_sp(i)^3/(3*r_np(i)^3);
43
44 elseif s(i) == 0
45
46 r_np(i) = a_exp(i);
47 delta_omega(i) = mu_0*gamma_I*N_exp(i)*m(i)*rho(i)*r_sp(i)^3/...
48 (3*r_np(i)^3);
49 f_A(i) = C_exp(i)*4/3*pi*a_exp(i)^3*corr(i);
50
51 elseif s(i) == 2
52
53 r_np(i) = a_exp(i);
54 delta_omega(i) = mu_0*gamma_I*m(i)*N_exp(i)*rho(i)*r_sp(i)^3/...
55 (3*r_np(i)^3);





61 tau_D_NP = r_np.^2./D;
62 tau_sdr = pi*sqrt(3)./(2.*delta_omega);
63 tau_L = (1.49./delta_omega).*(delta_omega.*TE).^(1/3).*...
64 (1.52 + f_A.*delta_omega.*TE).^(5/3);
65
66 MR = zeros(size(s));
67
68 for i = 1:length(s)
69
70 if delta_omega(i) < 1/tau_D_NP(i) || q(i) == 1
71
72 MR(i) = 16/45*f_A(i)*delta_omega(i)^2*tau_D_NP(i);
73
74 % Test for scaling law behavior; th: theory, ex: experimental
75 th = R2_mess(i)*corr(i)/(m(i)*rho(i)*r_sp(i)^3/(r_np(i)^3))^2;
76 ex = 11.6*10^( 12)*(2*r_np(i)*10^9)^2;
77
78 elseif tau_D_NP(i) > tau_sdr(i) && tau_D_NP(i) < tau_L(i) || q(i) == 2
79
80 MR(i) = 2*pi*sqrt(3)* f_A(i)*delta_omega(i)/9;
81




84 MR(i) = 1.8*f_A(i)*(delta_omega(i)*TE(i))^(1/3)*...




89 %% Calculation according to unified approach
90 a = 2.5209*10^12;
91 b =  0.177*10^9;
92 c = 0.1295*10^9;
93 d = 0.0523*10^9;
94 e = 0.0566*10^9;
95 z = 0.42;
96
97 s = [1, 1, 1, 0, 0, 2, 2, 2, 2, 2];
98 B_eq = m.*rho.*(r_sp./(r_sp+d_SPIO)).^3.*mu_0/3;
99 f_A = N_exp.*C_exp.*4/3*pi.*r_sp.^3;
100
101 R2 = zeros(1,10); B = zeros(3,10); f_bulk = zeros(1,10);
102 f_inner = zeros(1,10); R2_inner=zeros(1,10); R2_bulk=zeros(1,10);
103 p_bulk = zeros(1,10); p_inner = zeros(1,10);
104 for i = 1:length(s)
105
106 if s(i) == 1
107
108 f_A(i) = f_A(i)*(r_sp(i) + d_SPIO)^3/r_sp(i)^3*corr(i);
109 B (1,i) = B_eq(i); r_np(i) = r_sp(i)+d_SPIO;
110 R2(i) = f_A(i)*(a*B(1,i)*r_np(i))^2/(1 + b*r_np(i)*B(1,i)^z + ...
111 (c*r_np(i)*B(1,i)^z)^2 + (d*r_np(i)*B(1,i)^z)^3 + ...
112 (e*r_np(i)*B(1,i)^z)^4 );
113
114 elseif s(i) == 0
115
116 B(2,i) = B_eq(i)*N_exp(i)*(r_sp(i)+d_SPIO)^3/a_exp(i)^3;
117 r_np(i) = a_exp(i);
118 f_A(i) = C_exp(i)*4/3*pi*a_exp(i)^3*corr(i);
119
120 R2(i) = f_A(i)*(a*B(2,i)*r_np(i))^2/(1 + b*r_np(i)*B(2,i)^z + ...
121 (c*r_np(i)*B(2,i)^z)^2 + (d*r_np(i)*B(2,i)^z)^3 + ...
122 (e*r_np(i)*B(2,i)^z)^4 );
123
124 elseif s(i) == 2
125
126 r_np(i) = r_sp(i) + d_SPIO;
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127 B(3,i) = N_exp(i)*B_eq(i)*((r_sp(i)+d_SPIO)/a_exp(i))^3;
128 f_bulk(i) = C_exp(i)*4/3*pi*a_exp(i)^3*corr(i);
129
130 %For consideration of the right SPIOs
131 corr_2 = [0.53, 0.71, 0.76, .53, .53, .76, .71, .53, 0.71, 0.71];
132 f_inner(i) = N_exp(i)*(r_sp(i)+d_SPIO)^3/(a_exp(i) 15*10^ 9)^3*...
133 corr_2(i);
134
135 R2_inner(1,i) = f_inner(i)*(a*B_eq(i)*r_np(i))^2/...
136 (1 + b*r_np(i)*B_eq(i)^z + (c*r_np(i)*B_eq(i)^z)^2 + ...
137 (d*r_np(i)*B_eq(i)^z)^3 + (e*r_np(i)*B_eq(i)^z)^4 );
138 R2_bulk(1,i) = f_bulk(i)*(a*B(3,i)*a_exp(i))^2/...
139 (1 + b*a_exp(i)*B(3,i)^z + (c*a_exp(i)*B(3,i)^z)^2 + ...
140 (d*a_exp(i)*B(3,i)^z)^3 + (e*a_exp(i)*B(3,i)^z)^4 );
141
142 p_bulk(1,i) = 1 C_exp(i)*4/3*pi*a_exp(i)^3;
143 p_inner(1,i) = 1 p_bulk(i)   N_exp(i)*4/3*pi*...
144 (r_sp(i)+d_SPIO)^3 C_exp(i)*4/3*pi*...
145 (a_exp(i)^3   (a_exp(i) 15*10^ 9)^3);
146







154 %% Theoretical calculations
155 gamma_I = 2.675*10^8; % gyromagnetic ratio
156 mu_0 = 4*pi*10^ 7; % permeability of vacuum
157 mu_B = 9.274*10^ 24; % Bohr magneton
158 N_A = 6.02*10^23;
159 D = 2.27*10^ 9; % relative diffusion coefficient
160 k_B = 1.38*10^ 23; % Boltzmann constant
161 T = 310; % Absolute temperature
162 B_0 = 4.7; % static external field
163 V_EZ = 592.39*10^ 30;% Volume of unit cell of one Fe3O4 crystal
164 mu_sp = 4.1*mu_B; % magnetic moment
165 Delta_omega = 0.5*gamma_I*(8*mu_sp/V_EZ)*mu_0/3; % Difference larmor freq.
166 C_a = 10^ 6; % Agglomorate concentration
167 f_A = 5*10^ 6; % volumetric fraction of NP
168 t_e = 100*10^ 6; % Echo time
169
170 a2 = transpose(logspace( 9,  6, 150));
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171 a = a2 + 0.30.*a2.*randn(size(a2));
172 tau_D = zeros(length(a),1); R2=zeros(length(a), 5);
173 x = zeros(length(a),2); N_g = zeros(length(a)); L = zeros(length(a),2);
174
175 for i = 1 : length(a)
176
177 tau_D(i) = a(i)^2/D;
178
179 if Delta_omega*tau_D(i) < 1
180
181 N_g(i) = 8*4/3*pi*a(i)^3/V_EZ; % Number of elementary crystals
182 x(i,1) = N_g(i)*mu_sp*B_0/(k_B*T);
183 L(i,1) = coth(x(i))   1/x(i);
184




189 x = Delta_omega*t_e/2;
190
191 tau_L = (1.49/Delta_omega)*x^(1/3)*(1.52 + f_A(1)*x)^(5/3);
192
193 if tau_D < tau_L
194




199 R2(i, 1) = 1.8*f_A(1)*x^(1/3)*(1.52 + f_A(1)*x)^(5/3)/...
200 tau_D(i);
201 R2(i, 3) = 2*pi*sqrt(3)*f_A(1)*Delta_omega/9; % T2*
202
203 x = Delta_omega*2000*10^ 6/2;








212 plot(a2*10^9, R2(:, 1));
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